RESTORE INSULIN SENSITIVITY

/ SCIENCE, SOLUTIONS / By
  1. Metformin trims fats to restore insulin sensitivity
  2. The amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob mice
  3. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C
  4. Normalization of insulin sensitivity with lithium in diabetic rats
  5. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII
  6. D-chiro-inositol–its functional role in insulin action and its deficit in insulin resistance
  7. Exercise intensity, inflammatory signaling, and insulin resistance in obese rats.
  8. insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver
  9. FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
  10. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes
  11. Phospholipid environment alters hormone-insulin sensitivity of the purified insulin receptor kinase
  12. Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
  13. insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes
  14. n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator–activated receptor-α–dependent manner
  15. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-κB signaling …
  16. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs
  17. Metabolic impact of puberty on the course of type 1 diabetes.
  18. Activating the longevity gene to restore insulin sensitivity and immune reciprocity in patients with metabolic syndrome
  19. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine
  20. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats
  21. Co‐administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats
  22. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes
  23. Dehydroepiandrosterone decreases serum tumor necrosis factor-α and restores insulin sensitivity: independent effect from secondary weight reduction in genetically …
  24. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
  25. Liver-specific igf-1 gene deletion leads to muscle insulin ininsulin sensitivity
  26. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action
  27. Setting the stage: possible mechanisms by which acute contraction restores insulin sensitivity in muscle
  28. Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin …
  29. Short‐term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated
  30. Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats
  31. Linking mitochondrial bioenergetics to insulin resistance via redox biology
  32. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity
  33. The effect of N-stearoylethanolamine on liver phospholipid composition of rats with insulin resistance caused by alimentary obesity
  34. Dual effects of resveratrol on arterial damage induced by insulin resistance in aged mice
  35. Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans
  36. Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation
  37. The effect of salicylates on insulin sensitivity
  38. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway
  39. Curative diet supplementation with a melon superoxide dismutase reduces adipose tissue in obese hamsters by improving insulin sensitivity
  40. Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: A randomized double-blinded placebo-controlled …
  41. Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth
  42. The protein kinase IKKɛ regulates energy balance in obese mice
  43. Bioactives of Artemisia dracunculus L. enhance insulin sensitivity by modulation of ceramide metabolism in rat skeletal muscle cells
  44. Effect of Sutherlandia frutescens on the Lipid Metabolism in an insulin Resistant Rat Model and 3T3‐L1 Adipocytes
  45. Metabolic rescue of obese adipose-derived stem cells by Lin28/Let7 pathway
  46. Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals
  47. Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy.
  48. Modelling of detailed insulin receptor kinetics affects insulin sensitivity and noise in the downstream signalling pathway
  49. Leptin insulin sensitivity in skeletal muscle is modulated by diet and exercise
  50. Acute inactivity impairs glycemic control but not blood flow to glucose ingestion
  51. p53 Mediates impaired insulin signaling in 3T3‐L1 adipocytes during hyperinsulinemia
  52. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM
  53. Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells
  54. Chromium (III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model
  55. Pathways leading to muscle insulin resistance–the muscle–fat connection
  56. Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme
  57. Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension
  58. Pigment epithelium-derived factor contributes to insulin resistance in obesity
  59. insulin Resistance and β-Cell Dysfunction in Aging: The Importance of Dietary Carbohydrate
  60. Metabolic disruptions induced by reduced ambulatory activity in free-living humans
  61. Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease
  62. Phosphatidylinositol 4, 5-Bisphosphate Reverses Endothelin-1–Induced insulin Resistance via an Actin-Dependent Mechanism
  63. Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance
  64. Increased 24h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys
  65. S 15261, a novel agent for the treatment of insulin resistance. Studies on Psammomys obesus. Effect on pancreatic islets of insulin resistant animals.
  66. Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition
  67. insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
  68. Glyceollin improves endoplasmic reticulum stress-induced insulin resistance through CaMKK-AMPK pathway in L6 myotubes
  69. Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats
  70. Exploring off‐target binding of thiazolidinediones and a novel mechanism for restoring insulin sensitivity (854.2)
  71. Hyperinsulinemia induces insulin resistance on glucose and lipid metabolism in a human adipocytic cell line: paracrine interaction with myocytes
  72. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice
  73. Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic …
  74. Functional properties of Claramine: A novel PTP1B inhibitor and insulin-mimetic compound
  75. Niacin improves adiponectin secretion, glucose tolerance and insulin sensitivity in diet-induced obese rats
  76. insulin resistance and preeclampsia
  77. Modulation of PPARγ activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis
  78. Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2
  79. Andrographolide attenuates tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes
  80. Exercise and insulin resistance
  81. Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice
  82. Mitochondrial regulation of insulin action
  83. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
  84. New series of aryloxypropanolamines with both human β3-adrenoceptor agonistic activity and free radical scavenging properties
  85. Glycolipid metabolism disorder in the liver of obese mice is improved by TUDCA via the restoration of defective hepatic autophagy
  86. Impaired insulin sensitivity and insulin secretion in Haemodialysis patients with and without Secondary Hyperparathyroidism
  87. insulin resistance, a new target for nitric oxide‐delivery drugs
  88. KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production
  89. Metabolic inflexibility in skeletal muscle: a prelude to the cardiometabolic syndrome?
  90. Effect of acute exercise or fasting on mitochondrial function and high fat diet-induced insulin resistance
  91. A family of Acrp30/adiponectin structural and functional paralogs
  92. The relationship between the hyperplastic pancreatic islet and insulin ininsulin sensitivity in obesity
  93. Resveratrol action in the duodenum and the regulation of insulin sensitivity
  94. Comparing the correlation of measures of insulin sensitivity in youth.
  95. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance
  96. Obesity, immunomodulation and chronic kidney disease
  97. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing …
  98. insulin-like action of vanadium compounds in fat cells
  99. Fenretinide Induces Ubiquitin‐Dependent Proteasomal Degradation of Stearoyl‐CoA Desaturase in Human Retinal Pigment Epithelial Cells
  100. Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes
  101. The insulin-sensitizing role of the fat derived hormone adiponectin
  102. Abrogation of hyperosmotic impairment of insulin signaling by a novel class of 1, 2-dithiole-3-thiones through the inhibition of S6K1 activation
  103. The effect of manipulation of basal pulsatile insulin on insulin action in Type 2 diabetes
  104. insulin resistance and steatosis in hepatitis C virus infection
  105. The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients …
  106. Acute glucagon induces postprandial peripheral insulin resistance
  107. Skeletal muscle uncoupling protein‐3 restores upon intervention in the prediabetic and diabetic state: implications for diabetes pathogenesis?
  108. Interplay between FGF21 and insulin action in the liver regulates metabolism
  109. Fat accretion and the regulation of insulin-mediated glycogen synthesis after puberty in rats
  110. Fat cell insulin resistance: an experimental study focusing on molecular mechanisms in type 2 diabetes
  111. Therapeutic approaches to insulin resistance
  112. Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells
  113. Low RIP140 expression partially restores metabolic flexibility in L6 muscle cells treated with high FA
  114. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum
  115. Poker face no more: cancer recurrence reveals its hand
  116. Disclosing the caffeine dose to be administered that restores insulin sensitivity in prediabetes animal
  117. Are oxidative stress− activated signaling pathways mediators of insulin resistance and β-cell dysfunction?
  118. Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant type 2 diabetic patients.(Key …
  119. Periodontal therapy: a useful adjunct to improve glycemic control
  120. In human adipocytes exposed to high glucose and insulin levels, IRS-1 displays altered phosphorylation and may be targeted for degradation
  121. Protective effect of aspirin in relation to IGF-1 in streptozotocin induced type-II diabetic rats
  122. Apocynin, an NADPH Oxidase Inhibitor, Prevents Hepatic and Peripheral insulin Resistance Induced by Short-Term Lipid Infusion
  123. The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue
  124. DiaMedica to Deliver Poster Presentation at World Conference on Clinical Pharmacology and Therapeutics
  125. Lipid disorders in diabetes mellitus and current management
  126. insulin sensitivity: measurements in the whole body and in isolated tissues
  127. Cation-induced restoration of insulin action in insulin-desensitized HTC cells
  128. Potential of surgery for curing type 2 diabetes mellitus
  129. Neutralization of tumor necrosis factor reverses age-induced impairment of insulin responsiveness in skeletal muscle of Sprague-Dawley rats
  130. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
  131. Diabetes: An Unfolding Story
  132. Obesity surgery may cure diabetes in nonobese patients
  133. Clinical management strategies for type 2 diabetes
  134. Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat
  135. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies
  136. LMO4 is Required for Central Leptin Control of Fat Metabolism and insulin sensitivity.
  137. insulin sensitizing effects of oligomannuronate-chromium (III) complexes in C2C12 skeletal muscle cells
  138. Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance
  139. Anti-diabetic effects of benfotiamine on an animal model of type 2 diabetes mellitus
  140. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle
  141. Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet–fed mice
  142. Modulation of insulin resistance by PUFA in metabolic tissues
  143. SH2B1 Regulates insulin sensitivity and Glucose Homeostasis by Multiple Mechanisms.
  144. Hyperinsulin sensitivity to insulin during remissions in cyclosporin-treated IDDM patients
  145. Effect of antioxidant treatment on some indicators of obesity-induced changes in insulin sensitivity and beta-cell function in New Zealand white rabbits.
  146. Factors in serum from type 2 diabetes patients can cause cellular insulin resistance.
  147. Tadalafil ameliorates metabolic syndrome-induced alterations in visceral adipose tissue and liver: an experimental study in the rabbit
  148. Manipulation of the insulin-like growth factor 1 receptor on the vascular endothelium: the effect on whole body and endothelial specific insulin sensitivity
  149. Angiotensin II–induced insulin resistance is associated with enhanced insulin signaling
  150. EFFECT OF ASPIRIN PRETREATMENT IN STREPTOZOTOCINE INDUCED TYPE-II DIABETIC RATS
  151. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis
  152. Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletal muscle
  153. The FXR agonist obeticholic acid normalizes lipid droplet and triglyceride handling in visceral adipose tissue preadipocytes from a non-genomic rabbit model of …
  154. Sex differences in skeletal muscle Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) levels: A cross-sectional study
  155. N-3 Fatty Acids Preserve insulin sensitivity In Vivo in a PPARα-Dependent Manner
  156. Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin
  157. Dehydroepiandrosterone levels in Type 2 diabetes
  158. Effects of Exercise and Elevated Fatty Acid Availability on Muscle Lipid Metabolism and insulin sensitivity.
  159. insulin sensitivity and nutrient utilisation in skeletal muscle.
  160. Central Leptin, But Not Central insulin, Attenuates the Decrease of Adiponectin Concentrations and Increases insulin sensitivity in Streptozotocin (STZ)-Induced …
  161. Sirtuin 2 in hypothalamus: an emerging target in insulin resistance?
  162. Leucine-induced Impairment of insulin sensitivity in Skeletal Muscle of Healthy Rats is Reversible
  163. Reversible insulin sensitivity in Grizzly Bears (Ursus Arctos Horribilis): The Roles of Cell Autonomous and Exogenous Factors in Seasonal Glucose Metabolism
  164. N-stearoylethanolamine improves indicators of insulin resistance development under high-fat diet overload
  165. Heat shock proteins induction reduces stress kinases activation, potentially improving insulin signalling in monocytes from obese subjects
  166. Attenuation of Hepatic Leptin Signalling Leads to Improved Glucose Tolerance.
  167. Postprandial Free Fatty Acids (FFA) Metabolism Early in the Natural History of Type 2 Diabetes Mellitus (DM2)
  168. Ligand Binding Site AND Activity Correlations BY Hydrogen/Deuterium Exchange Mass Spectrometry
  169. Natural killer T cells
  170. DOES ASPIRIN PRETREATMENT PREVENT DIABETES IN RATS?
  171. Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase
  172. Genetic evidence points to an osteocalcin‐independent influence of osteoblasts on energy metabolism
  173. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic …
  174. Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans
  175. Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
  176. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice
  177. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo
  178. Diabetes: A fish story
  179. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site
  180. Effects of insulin resistance on substrate utilization during exercise in overweight women
  181. The kidney: an unwilling accomplice in syndrome X
  182. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development
  183. Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation
  184. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis
  185. Phosphorylation of IRS Proteins: Yin‐Yang Regulation of insulin Signaling
  186. T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor γ binding properties
  187. Osteopontin in obesity-associated adipose tissue inflammation and insulin resistance and its interaction with monocyte chemoattractant protein-1
  188. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-α induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X …
  189. Generation, validation and humanisation of a novel insulin resistant cell model
  190. Effects of inhibition of the renin‐angiotensin system on the cardiovascular actions of insulin
  191. The role of adenosine in insulin action coupling in rat adipocytes
  192. The role of diet and nutrient composition in nonalcoholic fatty liver disease
  193. Ozone exposure triggers insulin resistance through muscle c-Jun N-terminal kinase activation
  194. Impact of periodontitis on the diabetes-related inflammatory status
  195. Tissue specificity on insulin action and resistance: past to recent mechanisms
  196. Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPARα and γ agonist in healthy subjects and patients with type 2 diabetes
  197. Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms
  198. Thiazolidinediones in type 2 diabetes mellitus
  199. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus
  200. Sterols and Terpenoids from Viburnum odoratissimum
  201. Antioxidants: do they have a role in the treatment of insulin resistance?
  202. Proteomic analysis of the palmitate-induced myotube secretome reveals involvement of the annexin A1-formyl peptide receptor 2 (FPR2) pathway in insulin …
  203. Chronic ethanol consumption ameliorates the maturity-onset diabetes-obesity syndrome in CBA mice
  204. Palmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C θ and ε
  205. Deterioration of plasticity and metabolic homeostasis in the brain of the UCD-T2DM rat model of naturally occurring type-2 diabetes
  206. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet‐induced obese mice, independently of weight …
  207. An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice
  208. Fasting serum insulin and lipid levels in men with epilepsy
  209. Hyperthyroidism causes cardiac dysfunction by mitochondrial impairment and energy depletion
  210. The role of the lipogenic pathway in the development of hepatic steatosis
  211. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance
  212. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-α
  213. Defining the Importance of Fatty Acid Metabolism in Maintaining Adipocyte Function: A Dissertation
  214. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
  215. The role of s-nitrosothiols and rho-kinase 1 in glucose and lipid metabolism
  216. insulin resistance is a cellular antioxidant defense mechanism
  217. Turning off the inflammatory, but not the metabolic, flames
  218. Inhibitors of the lipid phosphatase SHIP2 discovered by high throughput affinity selection-mass spectrometry screening of combinatorial libraries
  219. Session 8: Mitochondria: from Biochemistry to Medicine Lectures Oral Presentations O8.
  220. Thujone, a component of medicinal herbs, rescues palmitate-induced insulin resistance in skeletal muscle
  221. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats
  222. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 …
  223. Reflections on inositol (s) for PCOS therapy: steps toward success
  224. Protein tyrosine phosphatases
  225. TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists
  226. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance
  227. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply
  228. insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management
  229. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes
  230. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
  231. Therapeutic roles of peroxisome proliferator–activated receptor agonists
  232. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
  233. Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance
  234. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia
  235. Conjugated linoleic acid may be useful in treating diabetes by controlling body fat and weight gain
  236. Brain signaling systems in the type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
  237. Reciprocal interference between insulin and interferon‐alpha signaling in hepatic cells: A vicious circle of clinical significance?
  238. insulin restores myocardial presynaptic sympathetic neuronal integrity in insulin-resistant diabetic rats
  239. Adipokines mediate inflammation and insulin resistance
  240. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor: a brute force approach based on “substrate-trapping” mutants
  241. Quercetin and quercetin‐3‐O‐glucuronide are equally effective in ameliorating endothelial insulin resistance through inhibition of reactive oxygen species …
  242. Optimization of cardiac metabolism in heart failure
  243. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes
  244. Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM
  245. Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury
  246. insulin secretion in hypothalamic obesity: Diurnal variation and the effect of naloxone
  247. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling
  248. Rat amylin-(8—37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats
  249. Dietary fat reduction and breast cancer outcome: results from the Women’s Intervention Nutrition Study (WINS)
  250. Poliphenolic-rich extracts from cocoa (Theobroma cacao L.) and cupuassu (Theobroma grandiflorum Willd. Ex Spreng. K. Shum) liquors: A comparison of metabolic …
  251. Differential effects of calorie restriction and exercise on the adipose transcriptome in diet-induced obese mice
  252. Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases
  253. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes
  254. Age-Appropriate Obesity Treatment
  255. FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival
  256. Gene and Cell Therapies for Diabetes Mellitus
  257. What we talk about when we talk about fat
  258. Chemerin induces insulin resistance in rat cardiomyocytes in part through the ERK1/2 signaling pathway
  259. The role of JNK proteins in metabolism
  260. insulin resistance in the offspring of parents with type 2 diabetes
  261. Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice
  262. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1‐year …
  263. Antioxidants in diabetic complications and insulin resistance
  264. Contribution of TNF-α to Obesity-Associated insulin Resistance
  265. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity
  266. Aetiology of non-insulin dependent diabetes
  267. Contribution of salt intake to insulin resistance associated with hypertension
  268. NLRP3 at the interface of metabolism and inflammation
  269. The critical role of metabolic pathways in aging
  270. Endothelial dysfunction in (pre) diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes
  271. Regulation of Skeletal Muscle insulin Action by SIRT1 and STAT3
  272. The HSP co-inducer BGP-15 can prevent the metabolic side effects of the atypical antipsychotics
  273. Effective surgical treatment of diabetes for the obese patient
  274. Mechanism and management of AKT inhibitor-induced hyperglycemia
  275. Toll-like receptor 4-induced endoplasmic reticulum stress contributes to impairment of vasodilator action of insulin
  276. AMPK activators–potential therapeutics for metabolic and other diseases
  277. The role of insulin resistance in peripheral vascular disease
  278. Palmitate-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis
  279. Novel concepts in insulin regulation of hepatic gluconeogenesis
  280. Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats
  281. When to use insulin in the maturity onset diabetic.
  282. Quantum medicine update
  283. Molecular targets related to inflammation and insulin resistance and potential interventions
  284. the treatment of non‐alcoholic steatohepatitis with thiazolidinediones
  285. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes
  286. Histone deacetylase HDAC8 promotes insulin resistance and β-catenin activation in NAFLD-associated hepatocellular carcinoma
  287. The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium
  288. Novel in vivo studies on the effect of ethanolic stick cherries extract in diabetes management
  289. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency: a randomized, controlled …
  290. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity
  291. Leptin regulation of the immune response and the immunodeficiency of malnutrition1
  292. Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats
  293. Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment
  294. The hypoglycemic effect of pumpkin seeds, Trigonelline (TRG), Nicotinic acid (NA), and D-Chiro-inositol (DCI) in controlling glycemic levels in diabetes mellitus
  295. Peroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistance
  296. Systematic review: Preventive and therapeutic applications of metformin in liver disease
  297. Chemokine expression in inflamed adipose tissue is mainly mediated by NF-κB
  298. Obesity, inflammation, and the potential application of pharmaconutrition
  299. Diabetes and gum disease: the diabolic duo
  300. Kinetics and molecular docking studies of pimarane-type diterpenes as protein tyrosine phosphatase (PTP1B) inhibitors from Aralia continentalis roots
  301. Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys
  302. Eosinophils reduce chronic inflammation in adipose tissue by secreting Th2 cytokines and promoting M2 macrophages polarization
  303. Process Development on the Enantioselective Enzymatic Hydrolysis of S-Ethyl 2-Ethoxy-3-(4-hydroxyphenyl)propanoate
  304. The beta cell function in NIDDM patients with secondary failure
  305. Inflammatory mechanisms in obesity
  306. Periodontal treatment with topical antibiotics improves glycemic control in association with elevated serum adiponectin in patients with type 2 diabetes mellitus
  307. Tissue-specific regulation and expression of heat shock proteins in type 2 diabetic monkeys
  308. Lipotoxicity versus adipotoxicity—the deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes
  309. Glucose Uptake and Its Consequence on Cardiomyocyte Function
  310. n− 3 Fatty acids and the metabolic syndrome
  311. Mechanisms in endocrinology: Non-alcoholic fatty liver disease in common endocrine disorders
  312. New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells
  313. Therapeutic targets of brain insulin resistance in sporadic Alzheimer’s disease
  314. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects
  315. Troxerutin reverses fibrotic changes in the myocardium of high-fat high-fructose diet-fed mice
  316. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes
  317. Angiotensin-converting enzyme inhibition delays onset of glucosuria with regression of renal injuries in genetic rat model of non-insulin-dependent diabetes mellitus
  318. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with …
  319. Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition
  320. Targeting host factors: a novel rationale for the management of hepatitis C virus
  321. Use of mouse models in studying type 2 diabetes mellitus
  322. Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents
  323. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease
  324. insulin relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein response‐dependent insulin resistance as a cause of obesity‐associated …
  325. Overexpression of vesicle-associated membrane protein (VAMP) 3, but not VAMP2, protects glucose transporter (GLUT) 4 protein translocation in an in vitro …
  326. Drug-induced disorders of glucose tolerance
  327. Pharmacological activation of thyroid hormone receptors elicits a functional conversion of white to brown fat
  328. Drug-induced hyperglycaemia and diabetes
  329. Diabetes in mice with selective impairment of insulin action in Glut4-expressing tissues
  330. Palmitate-Activated Macrophages Confer insulin Resistance to Muscle Cells by a Mechanism Involving
  331. Blocking CD40-TRAF6 interactions by small-molecule inhibitor 6860766 ameliorates the complications of diet-induced obesity in mice
  332. Use of insulin sensitizers in NASH
  333. The angiotensin-melatonin axis
  334. Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle
  335. The emerging role of thiazolidinediones in the treatment of diabetes-mellitus and related disorders
  336. Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents
  337. Development of leptin resistance in rat soleus muscle in response to high-fat diets
  338. Aging does not reduce heat shock protein 70 in the absence of chronic insulin resistance
  339. Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron
  340. The Relationship Among Obesity, Inflammation, and insulin Resistance
  341. Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages
  342. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects
  343. Hypermethylation of hepatic glucokinase and L-type pyruvate kinase promoters in high-fat diet–induced obese rats
  344. How metabolism generates signals during innate immunity and inflammation
  345. Targeting PGC-1α to control energy homeostasis
  346. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents
  347. The overexpression of carnitine palmitoyl transferase1 and its influence on the lipid metabolism of rat hepatocytes
  348. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism
  349. Sulfonylureas in NIDDM
  350. Pharmacological properties of the central antihypertensive agent, moxonidine
  351. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer’s disease
  352. Use of metformin in the treatment of polycystic ovary syndrome
  353. The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases
  354. The intersection of inflammation, insulin resistance and ageing: implications for the study of molecular signalling pathways in horses
  355. Reactive oxygen species play a causal role in multiple forms of insulin resistance
  356. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes
  357. Effectiveness of telmisartan as an adjunct to metformin in treating type II diabetes mellitus in rats
  358. Female rats are relatively more sensitive to reduced lipid versus reduced carbohydrate availability
  359. The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction
  360. My βIG Fat Math Model: β-Cell Compensation and Type 2 Diabetes
  361. Antihyperglycaemic properties of the ethyl acetate extract of Dennettia tripetala in diabetic rats
  362. Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment
  363. Obesity and adipose tissue expansion in Ossabaw swine
  364. Biphasic effect of alcohol intake on the development of fatty liver disease
  365. insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α‐2b plus ribavirin
  366. insulin-like growth factors and their binding proteins: biological actions
  367. Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
  368. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocyte cultures
  369. Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice
  370. Oral administration of immunoglobulin G‐enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells
  371. Bariatric surgery decreases monocyte-platelet aggregates in blood: a pilot study
  372. Nonalcoholic fatty liver disease: the potential role of nutritional management
  373. POSTERS: CLINICAL THERAPEUTICS/NEW TECHNOLOGY-TREATMENT OF insulin RESISTANCE
  374. A study of the biological activities of Avena sativa extracts
  375. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes
  376. insulin-like growth factor-related proteins and diabetic complications
  377. Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response.
  378. Novel “second-generation” approaches for the control of type 2 diabetes
  379. Reversal of obesity-induced hypertriglyceridemia by (R)-α-lipoic acid in ZDF (fa/fa) rats
  380. Anti-diabetic effects of polysaccharides from Opuntia monacantha cladode in normal and streptozotocin-induced diabetic rats
  381. MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide biosynthesis signaling, and glucose intolerance
  382. NPY signalling in early osteoblasts controls glucose homeostasis
  383. Pathophysiological Relevance of PPAR to Osteoarthritis: From the Control of Inflammation to Cartilage Protection?
  384. VEGF-B Blockade in muscle endothelium: a potential barrier to type 2 diabetes
  385. Nutritional and hormonal modulation of adiponectin and its receptors adipoR1 and adipoR2
  386. TNF-α and adipocyte biology
  387. Red Light Therapy for Diabetes and insulin Resistance
  388. George Q. Li,” Antony Kam,” Ka H. Wong,” Xian Zhou,’Eshaifol A. Omar,’Ali Alqahtani,” Kong M. Li,”
  389. Role of T cells in malnutrition and obesity
  390. Amino acids and mTORC1: from lysosomes to disease
  391. Pathogenesis of insulin resistance in metabolic obesity
  392. Anti-diabetic activity of Vaccinium bracteatum Thunb. leaves’ polysaccharide in STZ-induced diabetic mice
  393. 12-and 15-lipoxygenases in adipose tissue inflammation
  394. insulin Action at the Molecular Level: Facts and Speculations
  395. Adipocyte expression of PU. 1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production
  396. Tissue resident regulatory T cells: novel therapeutic targets for human disease
  397. Computational pharmacokinetics and in vitro-in vivo correlation of anti-diabetic synergistic phyto-composite blend
  398. Ozone exposure triggers insulin resistance through muscle c-Jun N-terminal Kinases (JNKs) activation
  399. Surgery in the treatment of type 2 diabetes mellitus
  400. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury
  401. Antihyperglycemic effects of the methanol leaf extract of Diaphananthe bidens in normoglycemic and streptozotocin–induced hyperglycemic rats
  402. Critical role of the Src homology 2 (SH2) domain of neuronal SH2B1 in the regulation of body weight and glucose homeostasis in mice
  403. The road less traveled: modulating signal transduction enzymes by inhibiting their protein–protein interactions
  404. Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and …
  405. Trauma and hemorrhage-induced acute hepatic insulin resistance: Dominant role of tumor necrosis factor-α
  406. Mechanisms of disease: mitochondrial dysfunction in sensory neuropathy and other complications in diabetes
  407. Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease
  408. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction
  409. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation …
  410. Carnitine in metabolic disease: potential for pharmacological intervention
  411. Ipragliflozin and other sodium–glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data
  412. Metabolic Control by Inflammation and Immunity: Toll-like receptor 4-induced endoplasmic reticulum stress contributes to impairment of vasodilator action of …
  413. Development of Personal UVB Sensor: Detection of Previtamin D Photosynthesis
  414. Implication of mitochondria endoplasmic-reticulum interactions in the control of hepatic metabolism
  415. Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis
  416. Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome
  417. Metformin modulates insulin post-receptor signaling transduction in chronically insulin-treated Heps G2 cells
  418. Effects of physical activity upon the liver
  419. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance
  420. A pharmacokinetic and pharmacodynamic study of pioglitazone in a model of induced insulin resistance in normal horses
  421. Effect of Vaccinium bracteatum Thunb. leaves extract on blood glucose and plasma lipid levels in streptozotocin-induced diabetic mice
  422. Effect of growth hormone on carbohydrate and lipid metabolism
  423. High speed development work by preparation of an “in‐hand” library of NMR‐quantified degradation products
  424. A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of …
  425. Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation
  426. Review of the roles of conjugated linoleic acid in health and disease
  427. The pro‐inflammatory environment in recalcitrant diabetic foot wounds
  428. Enhanced fatty acid flux triggered by adiponectin overexpression
  429. Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture
  430. The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible?
  431. Covalent peroxisome proliferator-activated receptor γ adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions
  432. insulin resistance and the modulation of rat cardiac K+ currents
  433. First Choice of Antihypertensive Therapy
  434. First Choice of Antihypertensive Therapy
  435. Moderate exercise restores pancreatic beta-cell function and autonomic nervous system activity in obese rats induced by high-fat diet
  436. Caffeine reduces TNFα up-regulation in human adipose tissue primary culture
  437. The hypoglycemic effect of Juglans regia leaves aqueous extract in diabetic patients: A first human trial
  438. Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?
  439. Genetic manipulation of Receptor Interacting Protein (RIP140) uncovers its critical role in the regulation of metabolism, gene expression and insulin signaling …
  440. Current and emerging treatment options in diabetes care
  441. Hypoglycaemic effects of fermented mycelium of Paecilomyces farinosus (G30801) on high-fat fed rats with streptozotocin-induced diabetes
  442. The pleiotropic functions of peroxisome proliferator-activated receptor γ
  443. Therapeutic use of recombinant methionyl human leptin
  444. Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus
  445. Mitochondrial pyruvate import and its effects on homeostasis
  446. Exercise pills: at the starting line
  447. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2
  448. Diabetes mellitus and periodontal diseases
  449. New progress in adipocytokine research
  450. Metabolomic analyses for atherosclerosis, diabetes, and obesity
  451. Chronic prenatal ethanol exposure increases adiposity and disrupts pancreatic morphology in adult guinea pig offspring
  452. Type 2 diabetes–tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines
  453. Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 …
  454. Hormonal control of diabetes type 2 after surgery: Clinical and experimental evaluation
  455. Old drug acquires new target: metformin and Sirt1
  456. Effects of vanadate on glucose production in cultured hepatocytes isolated from rats on high saturated fat diet
  457. Getting rid of JNK
  458. Separation of insulin signaling into distinct GLUT4 translocation and activation steps
  459. Weight-reduction through a low-fat diet causes differential expression of circulating microRNAs in obese C57BL/6 mice
  460. A detailed study on poly cystic ovarian syndrome and it’s treatment with natural products
  461. Cardiometabolic interventions–focus on transcriptional regulators
  462. Angiotensin-Converting Enzyme Inhibition Delays Onset
  463. Regulation of glucose transporter messenger RNA levels in rat adipose tissue by insulin
  464. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation
  465. Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity
  466. Possibility of ozone depletion monitoring in conditions of opaque atmosphere using D-dosimeter
  467. Composition and hypoglycemic effect of camel milk in streptozotocin-induced diabetic rats
  468. Apparent induction of partial thymic regeneration in a normal human subject: a case report
  469. Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights
  470. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress
  471. Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
  472. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update
  473. 12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response
  474. Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats
  475. Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs
  476. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice
  477. Protein kinase C: mediator or inhibitor of insulin action?
  478. The effect of 2-month bromocriptine treatment on the activity of the adenylyl cyclase signaling system in the myocardium and testes of rats with type 2 diabetes
  479. Oral hypoglycaemic agents.
  480. Kidney Failure Cause
  481. Diabetes mellitus and inflammatory periodontal diseases
  482. Genomics, nutrition, obesity, and diabetes
  483. Muscular response and adaptation to diabetes mellitus
  484. Tumor necrosis factor α (TNFα) stimulates Map4k4 expression through TNFα receptor 1 signaling to c-Jun and activating transcription factor 2
  485. Drug-induced diabetes mellitus
  486. Systems biology of adipose tissue metabolism: regulation of growth, signaling and inflammation
  487. Glucose control and integration by the skeleton
  488. Interrelationships between obesity and diabetes
  489. Plasma leptin levels after biliopancreatic diversion: dissociation with body mass index
  490. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans
  491. The sirtuin family’s role in aging and age-associated pathologies
  492. Mechanism and Management of AKT Inhibitor-Induced Hyperglycemia
  493. Mediterranean Diet is an Effective Method for Treating Type 2 Diabetes in Adults
  494. Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases–the pro and con of agonists
  495. Protein tyrosine phosphatase 1B inhibitory activity of alkaloids from Rhizoma Coptidis and their molecular docking studies
  496. Metabolic complications associated with HIV protease inhibitor therapy
  497. Polycystic Ovarian Syndrome: a new perspective
  498. Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-related metabolic, histological, and haemodynamic …
  499. Design, synthesis, and structure− activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal …
  500. Pharmacogenetics of Diabetes
  501. Type 4 Hyperlipoproteinemia: One Theory of Atherogenesis
  502. Anti-inflammatory and antidiabetic roles of PPAR gamma
  503. Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients—a …
  504. The nuts and bolts of AGC protein kinases
  505. D‐CHIRO‐INOSITOL FOUND IN MOMORDICA CHARANTIA FRUIT EXTRACT PLAYS A ROLE IN REDUCING BLOOD GLUCOSE IN STREPTOZOTOCIN‐DIABETIC …
  506. insulin receptor substrate (IRS)‐1 regulates murine embryonic stem (mES) cells self‐renewal
  507. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic β-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein …
  508. Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane
  509. Rosiglitazone reverses increased duodenal inhibitory response in spontaneously hypertensive rats
  510. The Medicinal Plant Sutherlandia Frutescens Regulates Gene Expression to Reverse insulin Resistace in Rats
  511. Momordica charantia and type 2 diabetes: from in vitro to human studies
  512. Thesis, antithesis, and synthesis in periodontal and systemic interlink
  513. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications
  514. Hepatitis C and steatosis
  515. Therapeutic potential of intravenously administered mesenchymal stem cells in diet-induced obesity
  516. Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone
  517. The effect of scaling and root planing on glycaemic control, periodontal status and gingival crevicular fluid TNF-α levels in an Indian population-to reveal the …
  518. Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a)
  519. Secondary Diabetes: Drug Induced Diabetes
  520. Metal-based anti-diabetic drugs: advances and challenges
  521. Extrahepatic morbidity and mortality of chronic hepatitis C
  522. Chemokine Expression in Inflamed Adipose Tissue Is Mainly Mediated
  523. Histone deacetylase HDAC8 promotes insulin resistance and-catenin
  524. PPAR ligands for the treatment of insulin resistance
  525. P2-455: The neurocognitive effects of donepezil on visual short-term memory capacity following 24 Hours of sleep deprivation
  526. Polycystic ovarian syndrome: a new perspective
  527. Inhibition of Vascular Endothelial Growth Factor Signaling Stimulates Erythropoiesis and Sensitizes Hepatic insulin Signaling Through Activation of Hepatic …
  528. Periodontitis and diabetes—a complex relationship
  529. Taurine in health and diseases: consistent evidence from experimental and epidemiological studies
  530. Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase–dependent pathway that is impaired with obesity
  531. Nigella sativa oil potentiates the effects of pioglitazone on long term alloxan-induced diabetic rats
  532. Ecology then and Now
  533. Thiazolidinedione therapy in a patient with diabetes after cardiac transplantation
  534. Soybean and processed soy foods ingredients, and their role in cardiometabolic risk prevention
  535. Role of Leucine in Modulation of Mitochondrial Biogenesis and SIRT1-AMPK Signaling in C2C12 Myotubes
  536. Plasma phospholipids n‐3 polyunsaturated fatty acid is associated with metabolic syndrome
  537. Endocrine and Metabolic Dysfunction during Aging and Senescence: MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide …
  538. insulin resistance and progression of heart failure in the older adult
  539. N-3 polyunsaturated fatty acids and inflammation in obesity: local effect and systemic benefit
  540. Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat type 2 diabetes
  541. Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
  542. Advanced proteomics procedure as a detection tool for predictive screening in type 2 pre-Diabetes
  543. Exercise-induced recovery of skeletal muscle insulin response is independent of adiponectin response in high-fat fed rodents
  544. Redox implications in adipose tissue (dys) function—a new look at old acquaintances
  545. Modulatory effects of diosgenin on attenuating the key enzymes activities of carbohydrate metabolism and glycogen content in streptozotocin-induced diabetic rats
  546. Role of MAP4K4 Signaling in Adipocyte and Macrophage Derived Inflammation: A Dissertation
  547. Freedom from Disease: The Breakthrough Approach to Preventing Cancer, Heart Disease, Alzheimer’s, and Depression by Controlling insulin
  548. Effects of age and acute submaximal exercise on inflammatory cytokines, cortisol, insulin, heat shock proteins and skeletal muscle mediators of energy homeostasis in …
  549. Metformin and metabolic diseases: a focus on hepatic aspects
  550. The role of PtdIns (4, 5) P2 and its regulatory proteins in the development of insulin resistance in cell culture models
  551. Pharmacological and Pharmaceutical Developments on Fagopyrum Tataricum
  552. THE HEPATITIS CVirus AND DIABETES MELLITUS ASSOCIATION: CHARACTERIZATION AND STUDIES OF RISK FACTORS, MECHANISMS, IMPLICATIONS AND …
  553. PMI 5011 regulates the ubiquitin proteasome system in skeletal muscle
  554. A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin‐targeted keratinocyte grafts
  555. The effects of potassium ions and denervation on protein synthesis and the transport of amino acids in muscle
  556. The role of WNT10B in physiology and disease
  557. Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin
  558. Regulation of carbohydrate metabolism by the farnesoid X receptor
  559. Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease
  560. Effects of transplantation and resection of a radiation-induced rat insulinoma on glucose homeostasis and the endocrine pancreas
  561. Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension
  562. Status of association studies linking diabetes mellitus and periodontal disease in India
  563. Critical Role of the Src Homology 2 (SH2) Domain of Neuronal SH2B1 in the Regulation of Body Weight and Glucose Homeostasis…
  564. The effect of a soy protein diet on attenuation of obesity-related pathologies in obese Zucker rats.
  565. Phosphorylation of insulin receptor substrate-1 in development of muscle insulin resistance
  566. What causes equine laminitis
  567. Pharmaceutical salts and cocrystals involving amino acids: a brief structural overview of the state-of-art
  568. Nuclear receptors: novel therapeutic targets for the treatment and prevention of atherosclerosis
  569. IKKβ and the anti-adipogenic effect of platelet-derived growth factor in human abdominal subcutaneous preadipocytes
  570. The role of sterol 12α-hydroxylase (Cyp8b1) in glucose homeostasis
  571. Suppression of nuclear factor-κB and stimulation of inhibitor κB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the …
  572. Repetitive DNA elements as mediators of genomic change in response to environmental cues
  573. Stop Inflammation Now!
  574. Chemical modulators working at pharmacological interface of target proteins
  575. Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity
  576. Biocatalysis: Synthesis of key intermediates for development of pharmaceuticals
  577. Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis
  578. Maassen3, A. Edo Meinders1
  579. Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside
  580. Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-α in adipocytes: Functional consequences on glucose transport
  581. Hyperinsulinemia Tends to Induce Growth Without Growth Hormone in Children with Brain Tumors After Neurosurgery
  582. Effect of scaling and root planing on serum interleukin-10 levels and glycemic control in chronic periodontitis and type 2 diabetes mellitus
  583. Ginkgolide C suppresses adipogenesis in 3T3-L1 adipocytes via the AMPK signaling pathway
  584. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment
  585. Angiotensin II receptors and drug discovery in cardiovascular disease
  586. Effect of weight-reduction in obese mice lacking toll-like receptor 5 and C57BL/6 mice fed a low-fat diet
  587. Clinical Pharmacology of Sulfonylureas
  588. CŞ BASICS
  589. Strengthening innate immunological weaponry against carcinogenesis
  590. Overnutrition, mTOR signaling, and cardiovascular diseases
  591. Heat Shock Proteins: Treating Metabolic Disease by Turning up the Heat
  592. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells
  593. Robust control in biology: From genes to cells to systems
  594. Factors affecting insulin-stimulated in vitro glucose oxidation in rat epididymal adipocytes
  595. The Endoplasmic reticulum and insulin signalling in adipocytes
  596. Diabetes: 8 strategies to put into practice
  597. Sleep apnea syndrome: implications on cardiovascular diseases
  598. Synthesis and characterization of insulin receptor partial agonists as a route to improved diabetes therapy
  599. c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges
  600. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat
  601. New treatments for chronic hepatitis C
  602. Identification of Biomarkers for Beta Cell Failure as Detection Tools for Predictive Screening in Type 2 Pre-diabetes
  603. Consequences of chronic inflammation in peritoneal dialysis
  604. Identification of a novel AS160 splice variant that regulates GLUT4 translocation and glucose-uptake in rat muscle cells
  605. Screening in Type 2 Pre-diabetes
  606. The Mechanisms Underlying Free Fatty Acid-induced Hepatic insulin Resistance
  607. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner
  608. Covalent peroxisome proliferator-activated receptorγ binding by nitro-fatty acids: Endogenous ligands act as selective modulators
  609. Review Article Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic Agents.
  610. Diabetes and Its Association With Periodontal Tissues
  611. Development and validation of a high-precision capillary electrophoresis method for main component assay of ragaglitazar
  612. Polycystic Ovary Syndrome, Obesity and insulin Resistance
  613. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases
  614. Hepatic effects of a fructose diet in the stroke-prone spontaneously hypertensive rat
  615. Beta-adrenoreceptor modulation of metabolic, endocrine and immunologic function during critical illness
  616. Coffee and type 2 diabetes risk
  617. Network analysis: a new approach to study endocrine disorders
  618. Metabolic and physiological studies in a rat model of type 2 diabetes
  619. Protective effects of SP600125 in a diet-induced rat model of non-alcoholic steatohepatitis
  620. Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor α/γ agonist ragaglitazar
  621. Feeding high oleic acid Canola oil or olive oil alters inflammation, insulin resistance and lipid metabolism in a rodent model of diet induced obesity
  622. Obesity-associated interleukin-6 contributes to hepatic insulin resistance in mice
  623. Role of PKB/Akt in liver diseases
  624. The race for interferon‐free HCV therapies: a snapshot by the spring of 2012
  625. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway
  626. Mouse Models to Study Metformin Effects in Carcinogenesis
  627. Lack of Angiopoietin‐Like‐2 Expression Limits the Metabolic Stress Induced by a High‐Fat Diet and Maintains Endothelial Function in Mice
  628. Molecular Mechanisms Involved in Inflammation and insulin Resistance in Chronic Diseases and Possible Interventions
  629. Glycerolipid metabolism and signaling in health and disease
  630. Adaptive enzyme responses in adipose tissue of obese hyperglycemic mice
  631. Transcriptional regulation of adipose insulin resistance
  632. The role of adiponectin and the adipocyte in energy metabolism and inflammation
  633. Development of thiadiazole as an antidiabetic agent-a review
  634. Caenorhabditis elegans, an invertebrate model organism for biomedical research
  635. Adipokines and redox signaling: impact on fatty liver disease
  636. The liver in metabolic syndrome
  637. Management of diabetic ketoacidosis
  638. Correlative studies on the effects of obesity, diabetes and hypertension on gene expression in omental adipose tissue of obese women
  639. Imidazoline receptors in insulin signaling and metabolic regulation
  640. Caenorhabditiselegans, An Invertebrate Model Organism for Biomedical Research
  641. The effects of pharmacological management of depression on HbA1c in type 2 diabetes
  642. The polycystic ovary syndrome–challenges and opportunities in adolescent medicine
  643. Histone Deacetylase 8 Promotes insulin Resistance and β-catenin Activation in NAFLD-associated Hepatocellular Carcinoma
  644. Reduction of hepatic steatosis in rats and mice after treatment with a liver‐targeted thyroid hormone receptor agonist
  645. Cardiovascular mortality and morbidity in dialysis patients
  646. Citrus ichangensis peel extract exhibits anti-metabolic disorder effects by the inhibition of PPAR and LXR signaling in high-fat diet-induced C57BL/6 mouse
  647. Cardiovascular disease in renal transplant recipients
  648. FEDERICO II
  649. Antihepatotoxic activity of a quantified Desmodium adscendens decoction and D-pinitol against chemically-induced liver damage in rats
  650. ATP non-competitive Ser/Thr kinase inhibitors as potential anticancer agents
  651. The clinical role of hepatocyte and commensal-probiotic cell physiology in the successful detoxification of carcinogenic toxicants
  652. Endocrine aspects of pulmonary hypertension
  653. Studies on the mechanisms of action and physiological relevance of SOCS proteins
  654. 13 Olive Oil in Metabolic
  655. Managing diabetes and periodontal disease.
  656. Upstream molecular signaling pathways of p27 (Kip1) expression in human breast cancer cells in vitro: differential effects of 4-hydroxytamoxifen and …
  657. Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly
  658. The outliers become a stampede as immunometabolism reaches a tipping point
  659. Cardiovascular risk factors following renal transplant
  660. Belinda P. Childs, ARNP, MN, CDE, BC-ADM, is a diabetes nurse spe-cialist
  661. Collaboratively constructed contradictory accounts: online organizational narratives
  662. Protein–Protein Interactions: A Simple Strategy to Identify Binding Sites and Peptide Antagonists
  663. Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s
  664. Metabolic hormones in bariatric surgery and reward behaviour
  665. STUDIES ON THE REGULATION OF FGF21 GENE EXPRESSION BY (R)-α-LIPOIC ACID: MECHANISTIC INSIGHT INTO THE LIPID LOWERING PROPERTIES OF A …
  666. Protein-protein interactions: network analysis and applications in drug discovery
  667. Outcomes of acute myocardial infarction in Type 2 diabetic Yemeni patients using different methods of treatment
  668. Non-systemic drugs: a critical review
  669. Mitochondrial energy failure in the eye induces loss of visual acuity in early metabolic syndrome: A novel therapeutic target
  670. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and …
  671. Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects
  672. Effect of nutrition education intervention and lifestyle behaviors on management of type 2 diabetes mellitus in Mwanza city, Tanzania
  673. Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic …
  674. Inhibitory Effect of Central Leptin on Hepatic Glucose Production in Streptozotocin (STZ)-Induced Diabetic Rats
  675. An association of boswellia, betaine and myo-inositol (Eumastós®) in the treatment of mammographic breast density: a randomized, double-blind study
  676. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48−/−Lepob/ob mice devoid of ApoE or Ldlr
  677. Therapeutical procedures to treat the metabolic syndrome in humans and animal models
  678. SCIENTIFIC SESSION ABSTRACTS
  679. Integrated characterization of cellular physiology underlying hepatic metabolism
  680. Metabolism and fatty acid profile in fat and lean rainbow trout lines fed with vegetable oil: effect of carbohydrates
  681. Cardiovascular Cells
  682. The Intricate Role of Adipokines in Immune-Mediated Diseases
  683. Endoplasmic reticulum stress is sufficient for the induction of IL-1β production via activation of the NF-κB and inflammasome pathways
  684. Feast or famine: Altered maternal nutrition and disease risk in offspring
  685. The Gut Microbiome–Clinical Implications for the Practicing Gastroenterologist
  686. The endothelial response to diabetes reveals a protective role for galectin-3 in diabetic vasculopathy and glucose metabolism
  687. Energy Balance and Cancer Risk: Metabolic and Molecular Studies
  688. Francesco Negro, Daniel Forton, 2 Antonio Craxì, 3 Mark S Sulkowski, 4 Jordan J. Feld, 5 Michael
  689. Discovery of peptides with balanced glucagon antagonism and GLP-1 agonism, supported by an investigation of their molecular basis for such action
  690. Curves: Permanent Results Without Permanent Dieting
  691. 15 Obesity and Type 2 Diabetes
  692. NON-PHARMACEUTICAL INTERVENTION OPTIONS FOR TYPE 2 DIABETES
  693. The Endocrine System
  694. dLipin- A Link Between Lipid Metabolism, Glucose Homeostasis and Growth in Drosophila melanogaster
  695. Role of the adipocyte in metabolism and endocrine function
  696. Chronic prenatal ethanol exposure produces neurobehavioural and metabolic dysfunction in guinea pig offspring
  697. Skeletal and Cardiac Muscle Energy Metabolism in Health and Disease
  698. 9 Mineral Deficiencies
  699. Mechanisms of Beta Cell Dysfunction and Application of Glp-1 Mimetics in Feline Diabetes Mellitus
  700. Regulation of the Mechanistic Target of Rapamycin by Cellular Stress.
  701. Negative regulation of the inflammasome: keeping inflammation under control
  702. Targeting mitochondrial function in diabetic nephropathy
  703. Developing C. elegans as a model to study Type 2 Diabetes Mellitus
  704. In Vivo Screening for Secreted Proteins That Modulate Glucose Handling Identifies Interleukin-6 Family Members as Potent Hypoglycemic Agents
  705. Terminal Modulator Protein (CTMP) regulates mitochondrial dynamics. PLoS One 4, e5471. Parone, PA, Da Cruz, S., Tondera, D., Mattenberger, Y., James, DI …
  706. First National Congress on Nutritional Medicine of the Dutch Nutraceutical Association
  707. The effect of conjugated linoleic acid (CLA) on sow and litter immune status and performance
  708. Proposed mechanisms underlining the potential effects of Staphylococcal superantigens on the development of type two diabetes
  709. Is there an embryopathy associated with first‐trimester exposure to angiotensin‐converting enzyme inhibitors and angiotensin receptor antagonists? A critical review …
  710. The Regulation of Net Hepatic Glucose Uptake in vivo
  711. STUDIES ON THE MECHANISMS OF ACTION AND PHYSIOLOGICAL RELEVANCE OF SOCS PROTEINS
  712. Achieving control of diabetic risk factors in primary care settings
  713. Hunger Free Forever: The New Science of Appetite Control
  714. Sweeteners and metabolic disorders
  715. Molecular aspects of alcohol metabolism: transcription factors involved in early ethanol-induced liver injury
  716. Jaypee Gold Standard Mini Atlas Series®: Diabetes
  717. TCF7L2 overexpression and type 2 diabetes: Dissecting the function of TCF7L2 as a regulator of glucose metabolism
  718. Multi-level regulation of argininosuccinate synthase: Significance for endothelial nitric oxide production
  719. Islet antibodies, autoimmunity, and β-cell function
  720. Continuous positive airway pressure therapy for sleep disordered breathing in adults
  721. GLP-1 CellBead Therapy for the Prevention of Left Ventricular Dysfunction in Pigs
  722. Promoting and maintaining physical activity in people with type 2 diabetes
  723. The Metabolic Syndrome and associated components among African women
  724. insulinoma
  725. Oxidative stress and inflammation as therapeutic targets of high-fat diet-induced metabolic diseases
  726. Cardiopulmonary and Quality of Life Responses of Individuals with Type 2 Diabetes to Therapeutic Excercises
  727. AMP-activated protein kinase, Sirtuin 1, and p53 interactions in HEPG2 cells
  728. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35
  729. The roles of ATF3 in stress-regulated signal transduction and cell death in pancreatic beta-cells
  730. The Role of the Cannabinoid Receptor Type 1 in Energy Balance, Glucose Metabolism, and Thermogenesis
  731. Phytanic acid alpha-oxidation, new insights into an old problem: a review
  732. Identification of bioactive compounds in wheat
  733. Diabetic macular oedema: the role of steroids and VEGF
  734. The Implications of CD36 Alteration on Rodent Skeletal Muscle Lipid Metabolism
  735. Adipose-derived Signals Induce Hyperplasia of the Mammary Epithelium in Response to 10e12z Conjugated Linoleic Acid Initiated Adipose Dysfunction
  736. Roles of ABCG5 ABCG8 cholesterol transporter in lipid homeostasis
  737. MEDICINE, SÃO PAULO, BRAZIL, OCTOBER 8–12, 2014
  738. Metabolic aspects of obesity
  739. Forkhead at the Crossroads of Cancer and Healthy Lifespan
  740. Metabolic Acidosis of Chronic Kidney Disease
  741. The Coconut Diet: The Secret Ingredient that Helps You Lose Weight While You Eat Your Favorite Foods
  742. Skeletal muscle fat infiltration is reversed by dietary fish oil in an animal model of colorectal cancer receiving irinotecan and 5-fluorouracil
  743. Dialed in
  744. Effects of chronic hyperglycemia on gene expression in streptozotocin-induced diabetic rats
  745. CHROMIUM SUPPLEMENTATION IN MANAGEMENT OF TYPE 2 DIABETES AMONG PATIENTS ATTENDING THIKA LEVEL 5 HOSPITAL, KENYA: A …
  746. Regulation of adipocyte and osteoblast differentiation by Wnt signaling
  747. Knowledge, opinions and practice behaviors of North Carolina endocrinologists’ and internists’ regarding periodontal disease and diabetes
  748. Unraveling the molecular physiology of the β-cell: genome wide analysis of binding sites for the transcription factor PDX1
  749. Cerebral blood flow and glucose metabolism in ischemic stroke: multimodal imaging investigations in a clinically relevant rat model
  750. Health promoting factors from milk of cows fed green plant material-The role of phytanic acid
  751. Fatty liver syndrome in mink-causes and metabolic consequences
  752. 4 Caloric Intake: Sources, Deficiencies
  753. List of Abstracts
  754. Effect of dietary polyunsaturated fatty acids on rat tissue oxylipin profiles
  755. Multi-modal Analysis of Metabolic Enzyme Disruption in Adipocytes
  756. The Design, Characterization, and Efficacy of Protease-Resistant Therapeutic Peptides
  757. MEDICAL LIBRARY
  758. Discovery and Characterization of Inflammation-Induced Electrophilic Fatty Acid Derivatives
  759. Becoming Vegan: The Complete Reference to Plant-Base Nutrition
  760. 12 CE in impurity profiling of drugs
  761. An Investigation of the Relationship Between Dermal Stresses and Foot Ground Stresses in Diabetic Patients
  762. Inhibition of Class I HDACs Blunts Cardiac Hypertrophy via TSC2-Dependent mTOR Repression
  763. In vitro screening assay using the murine pre-adipocyte cell line 3T3-L1 to study anti-obesogenic activities of cyanobacterial compounds
  764. HEALTH SEEKING BEHAVIOUR AND PATTERN OF ADHERENCE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN CENTRAL …
  765. Effects of vitamin A deficiency on retinoid and energy metabolism in liver and white adipose tissue
  766. CD64-mediated specific elimination of M1-polarized macrophages: implications for therapeutic intervention in chronic inflammatory diseases
  767. Recent Advances in Stem Cell Research
  768. Design and Synthesis of Functionalized Mn (III) Dipyrromethene Complexes as Peroxynitrite Decomposition Catalysts
  769. Thrive with diabetes
  770. The in vitro and in vivo anti-oxidative and anti-diabetic effects of some African medicinal plants and the identification of the bioactive compounds.
  771. Health seeking and health related behaviour for type 2 diabetes mellitus among adults in an urban community in Tanzania
  772. Manipulating Protein Stability with Small Molecules: Applications in studying biological systems and accessing new drug targets
  773. Message from Chief Guest
  774. Role of Endoplasmic Reticulum Stress Response Signaling in T Cells: A Dissertation
  775. Physiological Consequences of Compartmentalized Glycerolipid Synthesis
  776. Cost-effectiveness of disease interventions in India
  777. Putting ‘sugar diabetes’ on the table: Evaluating “The Sugar Plays” as entertainment-education in Appalachia
  778. Community Based Interactive Approach for Type 2 Diabetic Patients at Addaraja Health Center, Wad Medani, Sudan
  779. Emotional Vampires and Your Hormones: An Holistic Physician’s View on How Stress Affects Your Well-Being and What You Can Do About It
  780. The Role and Regulation of Sox9 in the Human Hair Follicle and Basal Cell Carcinoma
  781. A bittersweet existence: the lived experiences of four young women with diabetes mellitus
  782. Acid-base balance and oxidative metabolism in calcified tissues
  783. Investigation Into the Role of ER Stress in the Pathology of Metaphyseal Chondrodysplasia Type Schmid
  784. WNT SIGNALLING IN NORMAL DEVELOPMENT AND CANCER PROGRESSION
  785. … and insulin resistance: New targets encourage new thinking: Galectin‐3 and LTB4 are pro‐inflammatory molecules that can be targeted to restore insulin sensitivity
  786. Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore insulin sensitivity in the Diet-Induced Obesity in Vivo Mouse Model
  787. Interleukin-4 restores insulin sensitivity in lipid-induced insulin-resistant adipocytes
  788. Two nights of recovery sleep restores the dynamic lipemic response, but not the reduction of insulin sensitivity, induced by five nights of sleep restriction
  789. Cutting calories and TXNIP from the skeletal muscle to restore insulin sensitivity
  790. Gal3 links inflammation and insulin resistance
  791. Avocatin B Protects Against Lipotoxicity and Improves insulin sensitivity in Diet‐Induced Obesity
  792. A novel recombinant peptide INSR-IgG4Fc (Yiminsu) restores insulin sensitivity in experimental insulin resistance models
  793. Suppression of GATA-3 increases adipogenesis, reduces inflammation and improves insulin sensitivity in 3T3L-1 preadipocytes
  794. Chaperone-based therapeutic target innovation: Heat shock protein 70 (HSP70) for Type 2 diabetes mellitus
  795. Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance
  796. Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2
  797. Cardiovascular and Metabolic Consequences of Sleep and/or Circadian Disruption: Two nights of recovery sleep restores the dynamic lipemic response, but …
  798. Mitochondria and endoplasmic reticulum: Targets for a better insulin sensitivity in skeletal muscle?
  799. Developmental programming: impact of gestational steroid and metabolic milieus on mediators of insulin sensitivity in prenatal testosterone–treated female sheep
  800. Long-term rates of mitochondrial protein synthesis are increased in mouse skeletal muscle with high-fat feeding regardless of insulin-sensitizing treatment
  801. Adipocyte JAK2 regulates hepatic insulin sensitivity independently of body composition, liver lipid content, and hepatic insulin signaling
  802. Tumour necrosis factor α induces neuroinflammation and insulin resistance in immortalised hypothalamic neurones through independent pathways
  803. Impact of sleep deprivation and high-fat feeding on insulin sensitivity and beta cell function in dogs
  804. Functional abolition of carotid body activity restores insulin action and glucose homeostasis in rats: key roles for visceral adipose tissue and the liver
  805. Targeting insulin resistance with selected antidiabetic agents prevents menopausal associated central obesity, dysglycemia, and cardiometabolic risk
  806. Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice
  807. Obesity-associated alterations in glucose metabolism are reversed by chronic bilateral stimulation of the abdominal vagus nerve
  808. The manifold role of the mitochondria in skeletal muscle insulin resistance
  809. S-Nitrosoglutathione Reverts Dietary Sucrose-Induced insulin Resistance
  810. High frequency shift in Carotid Sinus Nerve and Sympathetic Nerve activity in Type 2 Diabetic Rat Model*
  811. Nutrient restriction increases circulating and hepatic ceramide in dairy cows displaying impaired insulin tolerance
  812. Obesity in menopause–our negligence or an unfortunate inevitability?
  813. Effect of aging on current flow due to transcranial direct current stimulation
  814. TXNIP in metabolic regulation: physiological role and therapeutic outlook
  815. Increased insulin sensitivity by High-Altitude Hypoxia in Mice with High-Fat Diet-Induced Obesity Is Associated with Activated AMPK Signaling and Subsequently …
  816. Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation
  817. Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance
  818. Reactive oxygen species enhance mitochondrial function, insulin sensitivity and glucose uptake in skeletal muscle of senescence accelerated prone mice SAMP8
  819. Effects of a ruthenium schiff base complex on glucose homeostasis in diet-induced pre-diabetic rats
  820. The transcription factor Prep1 controls hepatic insulin sensitivity and gluconeogenesis by targeting nuclear localization of FOXO1
  821. Protocatechuic acid exhibits hepatoprotective, vasculoprotective, antioxidant and insulin-like effects in dexamethasone-induced insulin-resistant rats
  822. Interleukin-4 Restores insulin sensitivity in insulin-Resistant Osteoblasts by Increasing the Expression of insulin Receptor Substrate 1
  823. Plant Bioactives and the Intestinal Barrier: Redox Signaling and Implications for insulin Resistance
  824. Regulation of insulin sensitivity by Skeletal Muscle Specific Modulation Of p21‐Activated Kinase 1 (PAK1)
  825. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates
  826. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice
  827. Oridonin prevents insulin resistance–mediated cognitive disorder through PTEN/Akt pathway and autophagy in minimal hepatic encephalopathy
  828. Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface
  829. A hypothesis for insulin resistance in primary human adipocytes involving MRTF-A and suppression of PPARγ
  830. Cefdinir microsphere modulated microflora and liver immunological response to diet induced diabetes in mice
  831. Effect of single anastomosis duodenal-ileal bypass with sleeve gastrectomy on glucose tolerance test: comparison with other bariatric procedures
  832. Exercise and polycystic ovary syndrome
  833. Hematopoietic Cell–Expressed Endothelial Nitric Oxide Protects the Liver From insulin Resistance
  834. insulin resistance and Parkinson’s disease: a new target for disease modification?
  835. Arginase inhibition prevents the development of hypertension and improves insulin resistance in obese rats
  836. Protective role of osteocalcin in diabetes pathogenesis
  837. Serum Level of Galectin-3 and Its Relation to insulin Resistance in Patients with Androgenetic Alopecia
  838. Effect of thiazolidinediones on adipocytokines and lipid profile in insulin resistant sprague dawley rats
  839. Transcranial direct current stimulation (tDCS) improves cognitive-motor performance in older adults with cerebral microvascular disease
  840. IL-17A contributes to propagation of inflammation but does not impair adipogenesis and/or insulin response, in adipose tissue of obese individuals
  841. Mitochondrial (Dys) function and insulin resistance: from pathophysiological molecular mechanisms to the impact of diet
  842. THE EFFECTS OF SLEEP RESTRICTION AND SUBSEQUENT SLEEP RECOVERY ON GLYCEMIC AND LIPEMIC METABOLISM.
  843. Anthocyanin Improves Glucose Homeostasis in Obese Mice via Regulation of Intestinal Microbiota and Barrier Function
  844. Could vagus nerve stimulation have a role in the treatment of diabetes?
  845. Mitochondria Dysfunction in Aging and Metabolic Diseases: Long-term rates of mitochondrial protein synthesis are increased in mouse skeletal muscle with …
  846. Impact of exercise on glucose homeostasis in different mouse models for impaired insulin sensitivity
  847. The metabolic stress response to burn trauma: current understanding and therapies
  848. 2-Arachidonoylglycerol ameliorates inflammatory stress-induced insulin resistance in cardiomyocytes
  849. insulin Resistance and T1D: The Effect of Exercise on Skeletal Muscle Lipid Metabolism
  850. SGLT inhibitors for type 1 diabetes: an obvious choice or too good to be true?
  851. The Effects of Western-diet, Palmitate, and TNFα on Hypothalamic Circadian Rhythms, NPY Expression, Neuroinflammation, and Cellular insulin sensitivity
  852. The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight …
  853. 9-Therapeutic Targeting of Skeletal Muscle Nix in Early-Onset insulin Resistance
  854. Regulation of skeletal muscle insulin sensitivity by PAK1
  855. Coordinated transcriptional control of adipocyte triglyceride lipase (Atgl) by transcription factors Sp1 and peroxisome proliferator–activated receptor γ (PPARγ) …
  856. The in Silico Study of Nutmeg Seeds (Myristica fragrans Houtt) as Peroxisome Proliferator Activated Receptor Gamma Activator Using 3D-QSAR …
  857. Modulation of visfatin levels by thiazolidinediones in insulin resistant sprague dawley rats
  858. Synergistic Effect of Two Major Components of Malva verticillata in the Recovery of Alloxan-Damaged Pancreatic Islet Cells in Zebrafish
  859. TNF-α as an Adipokine
  860. Anti-diabetic effects of excipients: possibility of formulation of an anti-diabetic dosage form using pharmaceutical excipients or their constituents, or food …
  861. 12-Examining the Role of the HNF-1a G319S Variant in Liver Function and Early-Onset Type 2 Diabetes
  862. 11-Investigating the Roles of Transcription Factor EB (TFEB) in β-Cell Function and Survival Under Stress
  863. Treatment of insulin resistance: straight from the gut
  864. Revisiting Caloric Restriction as Therapeutic Strategy for Metabolic Syndrome, T2DM and Obesity
  865. Reducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acids
  866. Ad libitum weekend recovery sleep fails to prevent metabolic dysregulation during a repeating pattern of insufficient sleep and weekend recovery sleep
  867. Mechanisms of macrophage polarization in insulin signaling and insulin sensitivity
  868. Why We Age: From Healthy Aging
  869. PPARγ in complex with an antagonist and inverse agonist: a tumble and trap mechanism of the activation helix
  870. IRS posttranslational modifications in regulating insulin signaling
  871. Adiponectin and aldosterone in left ventricular hypertrophy: an intriguing interplay
  872. Overview of ketone-based metabolism
  873. UNRAVELING THE LINK BETWEEN CAROTID BODY, insulin AND DOPAMINE.
  874. Role of Omega-3 Fatty Acids in Metabolic Syndrome
  875. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease
  876. Antidiabetic effect of casein glycomacropeptide hydrolysates on high-fat diet and STZ-induced diabetic mice via regulating insulin signaling in skeletal muscle and …
  877. Developmental programming: insulin sensitizer prevents the GnRH-stimulated LH hypersecretion in a sheep model of PCOS
  878. Poly (I: C) alleviates obesity related pro-inflammatory status and promotes glucose homeostasis
  879. The Effects of Estrogen, Grape Pomace, and Resveratrol Supplementation on Glucose Tolerance and insulin Signaling in Ovariectomized Rats.
  880. Casein glycomacropeptide hydrolysates ameliorate hepatic insulin resistance of C57BL/6J mice challenged with high-fat diet
  881. Knockdown of PTRF ameliorates adipocyte differentiation and functionality of human mesenchymal stem cells
  882. AMPK activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and ameliorates insulin resistance in obesity
  883. Markedly improved glycemic control in poorly controlled type 2 diabetes following direct acting antiviral treatment of genotype 1 hepatitis C
  884. Fructose induced neurogenic hypertension mediated by overactivation of p38 MAPK to impair insulin signaling transduction caused central insulin resistance
  885. Characterizing the Mechanisms of insulin Resistance in Dairy Cattle
  886. Preventive effect of oleate on palmitate-induced insulin resistance in skeletal muscle and its mechanism of action
  887. Vitamin D deficiency causes insulin resistance by provoking oxidative stress in hepatocytes
  888. CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5
  889. Rosiglitazone improves insulin resistance mediated by 10, 12 conjugated linoleic acid in a male mouse model of metabolic syndrome
  890. insulin resistance elicited in postpubertal primate offspring deprived of estrogen in utero
  891. Houttuynia cordata facilitates metformin on ameliorating insulin resistance associated with gut microbiota alteration in OLETF rats
  892. Class effect for SGLT-2 inhibitors: a tale of 9 drugs
  893. Paeoniflorin suppresses lipid accumulation and alleviates insulin resistance by regulating the Rho kinase/IRS-1 pathway in palmitate-induced HepG2Cells
  894. Vitamin D deficiency enhances insulin resistance by promoting inflammation in type 2 diabetes
  895. Soluble CD14 inhibits contractile function and insulin action in primary adult rat cardiomyocytes
  896. Cyanidin-3-O-glucoside restores insulin signaling and reduces inflammation in hypertrophic adipocytes
  897. Role of probiotics in diabetes: a review of their rationale and efficacy
  898. Uncovering the Complex Metabolic Role of Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT)
  899. Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice
  900. Metabolomic response of skeletal muscle to aerobic exercise training in insulin resistant type 1 diabetic rats
  901. TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl) purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway
  902. Long-term hypercaloric diet consumption exacerbates age-induced metabolic dysfunction: Beneficial effects of CSN denervation
  903. The effect of electric field, magnetic field, and infrared ray combination to reduce HOMA-IR index and GLUT 4 in diabetic model of Mus musculus
  904. Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study
  905. Decreased RNF41 expression leads to insulin resistance in skeletal muscle of obese women
  906. Polyphenol‐rich virgin olive oil reduces insulin resistance and liver inflammation and improves mitochondrial dysfunction in high‐fat diet fed rats
  907. Targeting inflammation and downstream protein metabolism in sarcopenia: a brief up-dated description of concurrent exercise and leucine-based multimodal …
  908. Oleuropein ameliorates palmitate-induced insulin resistance by increasing Glut4 translocation through activation of AMPK
  909. Pharmacological targeting of the unfolded protein response for disease intervention
  910. Effect of ionic liquid components on the coil dimensions of PEO
  911. The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease
  912. Purple sweet potato color improves hippocampal insulin resistance via down-regulating SOCS3 and galectin-3 in high-fat diet mice
  913. Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome
  914. Redox-Responsive Dipeptide Nanostructures toward Targeted Cancer Therapy
  915. Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition
  916. Inhibition of mitochondrial fission and iNOS in the dorsal vagal complex protects from overeating and weight gain
  917. Role of pro-and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity
  918. C-Phycocyanin inhibits hepatic gluconeogenesis and increases glycogen synthesis via activating Akt and AMPK in insulin resistance hepatocytes
  919. Mesoporous TiO2 Support Materials for Ru-Based CO2 Methanation Catalysts
  920. Developmental programming of PCOS traits: insights from the sheep
  921. The Potential Anti-Diabetic Effects of Some Plant Species
  922. Pharmacological Targeting of IRE1α Ameliorates insulin Resistance Through Preservation of the insulin Receptor Signaling Pathway
  923. Protocatechuic acid improves hepatic insulin resistance and restores vascular oxidative status in type-2 diabetic rats
  924. Starvation, carbohydrate loading, and outcome after major surgery
  925. Current trends in small molecule discovery targeting key cellular signaling events towards the combined management of diabetes and obesity
  926. Metformin in the treatment of adults with type 2 diabetes mellitus
  927. Ab Initio Study of CO2 Capture Mechanisms in Aqueous 2-Amino-2-methyl-1-propanol: Electronic and Steric Effects of Methyl Substituents on the Stability of …
  928. Coordinated regulation of miR-27 by insulin/CREB/Hippo contributes to insulin resistance
  929. Adiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet
  930. Exercise and insulin resistance in PCOS: muscle insulin signalling and fibrosis
  931. The role of dietary fat in obesity-induced insulin resistance
  932. Disturbances in insulin–Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes
  933. Manipulation of the growth hormone-insulin-like growth factor (GH-IGF) axis: A treatment strategy to reverse the effects of early life developmental programming
  934. The Effect of Bean Juice for Reduction Blood Glucose Levels in Psychological Stress
  935. Osteocalcin prevents insulin resistance, hepatic inflammation, and activates autophagy associated with high-fat diet–induced fatty liver hemorrhagic syndrome …
  936. Anti-inflammatory effect of piperine ameliorates insulin resistance in monosodium glutamate–treated obese mice
  937. Niclosamide as an anti-obesity drug: an experimental study
  938. Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients
  939. Bortezomib attenuates palmitic acid-induced ER stress, inflammation and insulin resistance in myotubes via AMPK dependent mechanism
  940. Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice
  941. Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study
  942. insulin signalling in hypothalamic neurones
  943. PPARG post-translational modifications regulate bone formation and bone resorption
  944. Regulation of hepatic glucose metabolism in health and disease
  945. Mechanisms of insulin action and insulin resistance
  946. Relationship between metabolic disorders and breast cancer incidence and outcomes. Is there a preventive and therapeutic role for berberine?
  947. Neratinib protects pancreatic beta cells in diabetes
  948. IP6K1 reduces mesenchymal stem/stromal cell fitness and potentiates high fat diet‐induced skeletal involution
  949. Nigella sativa L. oil ameliorates insulin resistance caused by dexamethasone treatment in male Wistar rats
  950. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders
  951. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR) α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin …
  952. Quantitative in vivo proteomics of metformin response in liver reveals AMPK-dependent and-independent signaling networks
  953. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell
  954. Adipocytes properties and crosstalk with immune system in obesity‐related inflammation
  955. Cinnamon extract combined with high-intensity endurance training alleviates metabolic syndrome via non-canonical WNT signaling
  956. Metformin reverses established lung fibrosis in a bleomycin model
  957. Towards resolving the enigma of the dichotomy of resveratrol: cis-and trans-resveratrol have opposite effects on TyrRS-regulated PARP1 activation
  958. Elevated Carbohydrate Response Element-Binding Protein Beta (ChREBPβ) and Thioredoxin Interacting Protein (TXNIP) Levels in Human Adipocytes Differentiated …
  959. insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and Porcupine
  960. Mesenchymal stem cell therapy in type 2 diabetes mellitus
  961. NHX-5, an endosomal Na+/H+ exchanger, is associated with metformin action
  962. Effects of zingiber officinale extract supplementation on metabolic and genotoxic parameters in diet-induced obesity in mice
  963. Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis
  964. The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)–mediated glucose uptake into skeletal muscle cells
  965. Role of gut microbiota in type 2 diabetes pathophysiology
  966. Rac1 and AMPK account for the majority of muscle glucose uptake stimulated by ex vivo contraction but not in vivo exercise
  967. Lower Blood Sugar Prevents Diabetes
  968. Role of hyperglycaemia in the relationship between serum osteocalcin levels and relative skeletal muscle index
  969. Role of the blood-brain barrier in central nervous system insulin resistance
  970. Promising inhibitory effects of anthraquinones, naphthopyrone, and naphthalene glycosides, from Cassia obtusifolia on α-glucosidase and human protein tyrosine …
  971. Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver
  972. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future
  973. Alkaloids potential health Benefits and toxicity
  974. Innate lymphoid cells as novel regulators of obesity and its‐associated metabolic dysfunction
  975. Protein tyrosine phosphatase 1B (PTP1B): a potential target for Alzheimer’s therapy?
  976. Xenobiotic mediated diabetogenesis: Developmental exposure to dichlorvos or atrazine leads to type 1 or type 2 diabetes in Drosophila
  977. Closed-loop control systems–The quest for precision therapies for diabetes
  978. Potential Protective Effects of Neonatal Supplementation with Oleanolic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)-Ligand Dependent …
  979. Bone-derived factors: a new gateway to regulate glycemia
  980. Angiotensin receptor subtypes regulate adipose tissue renewal and remodelling
  981. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
  982. Evaluation of DEFB1 polymorphisms in individuals with chronic periodontitis and diabetes mellitus type 2 in a population of northeastern Brazil
  983. Possible effects of dietary anthocyanins on diabetes and insulin resistance
  984. New Era of Perio Systemic Interrelationship
  985. Anti-adiposity impact of phosphodiesterase-5 inhibitor, Sildenafil is possibly through browning of white adipose tissue and FGF21 in obese rats
  986. Developmental programming: gestational testosterone excess disrupts LH secretion in the female sheep fetus
  987. Glucose-lowering Strategies in Diabetes: Pharmacological Development of New Anti-diabetic Drugs
  988. Dietary 23-hydroxy ursolic acid protects against diet-induced weight gain and hyperglycemia by protecting monocytes and macrophages against nutrient stress …
  989. Influence on hydrate dissociation for methane hydrates formed in the presence of PolyVinylCaprolactam versus PolyVinylCaprolactam+ Butyl Glycol Ether
  990. Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized …
  991. Acute effects of active breaks during prolonged sitting on subcutaneous adipose tissue gene expression: an ancillary analysis of a randomised controlled trial
  992. Thyroid hormone analogues: An update
  993. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin
  994. Increased mitochondrial calcium uniporter in adipocytes underlies mitochondrial alterations associated with insulin resistance
  995. The Effects of Solvent Polarity on Hypoglycemic and Hypolipidemic Activities of Vaccinium Arctostaphylos L. Unripe Fruits
  996. Inflammatory features of obesity and smoke exposure and the immunologic effects of exercise
  997. The apelin/APJ system as a therapeutic target in metabolic diseases
  998. For Management of Obesity and Diabetes: Is Timing the Answer?
  999. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
  1000. Biohydrogenation of linoleic acid by lactic acid bacteria for the production of functional cultured dairy products: A review
  1001. Resistin in metabolism, inflammation, and disease
  1002. Tailoring treatment for PCOS phenotypes
  1003. Growth hormone and insulin signaling in acromegaly: impact of surgery versus somatostatin analog treatment
  1004. DUSP5 Regulation of Inflammation and insulin Signaling
  1005. Bariatric and metabolic therapies targeting the small intestine
  1006. Essential roles for the non-canonical IκB kinases in linking inflammation to cancer, obesity, and diabetes
  1007. The effect of type 2 diabetes diagnosis in the elderly
  1008. Sexual function, obesity, and weight loss in men and women
  1009. The chronic effects of dietary (poly) phenols on mitochondrial dysfunction and glucose uptake in cellular models of the liver and skeletal muscle.
  1010. Does improved periodontal health affect metabolic and inflammatory markers in patients with diabetes mellitus? A comparative study
  1011. Nitric oxide exerts basal and insulin-dependent anorexigenic actions in POMC hypothalamic neurons
  1012. Resveratrol and quercetin administration improves antioxidant DEFENSES and reduces fatty liver in metabolic syndrome rats
  1013. Identification of putative biomarkers for type 2 diabetes using metabolomics in the Korea Association REsource (KARE) cohort
  1014. Downregulation of miR-181a alleviates renal fibrosis in diabetic nephropathy mice
  1015. Protective Effects and Mechanisms of Action of methyl-GBB in the Preclinical Models of Diabetes and Its Complications. Summary of the Doctoral Thesis
  1016. VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses
  1017. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome
  1018. Comorbidities and nonalcoholic fatty liver disease: the chicken, the egg, or both?
  1019. Deletion of TXNIP mitigates high-fat diet-impaired angiogenesis and prevents inflammation in a mouse model of critical limb ischemia
  1020. Thyroid hormone mimetics: the past, current status and future challenges
  1021. The effects of a [3+ 1] oxo-free rhenium (V) compound with uracil-derived ligands on selected parameters of glucose homeostasis in diet-induced pre-diabetic …
  1022. Autoimmunity, Non-Classic Adrenal Hyperplasia, insulin Resistance, and Vitamin D
  1023. Effects of ursodeoxycholic acid and insulin on palmitate-induced ROS production and down-regulation of PI3K/Akt signaling activity
  1024. Changes in Mitochondrial Dynamics and iNOS in the Dorsal Vagal Complex of the Brain affects insulin Sensing, Feeding Behaviours and Body Weight Gain in Rats
  1025. Intestinal microbiota and the immune system in metabolic diseases
  1026. AMPK: guardian of metabolism and mitochondrial homeostasis
  1027. insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and Porcupine
  1028. Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
  1029. Five stages of progressive β-cell dysfunction in the laboratory Nile rat model of type 2 diabetes
  1030. insulin resistance disrupts epithelial repair and niche-progenitor Fgf signaling during chronic liver injury
  1031. Targeting glucosylceramide synthesis in the treatment of rare and common renal disease
  1032. The immune system and microbiome in pregnancy
  1033. Ultra‐Performance Liquid Chromatography‐Mass Spectrometry Analysis of Free and Esterified Oxygenated Derivatives from Docosahexaenoic Acid in Rat Brain
  1034. Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes
  1035. Cardiolipin content controls mitochondrial coupling and energetic efficiency in muscle
  1036. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions
  1037. Novel Aspects of Adipocyte Biology: Increased mitochondrial calcium uniporter in adipocytes underlies mitochondrial alterations associated with insulin …
  1038. The role of the autonomic nervous system in the pathophysiology of obesity
  1039. Insights into the Functional Roles of Exercise in Type 2 Diabetes Using In Vitro Models
  1040. Wingless-type MMTV integration site family member 5a: a novel biomarker regulated in type 2 diabetes mellitus and diabetic kidney disease
  1041. Investigating the Wnt/β-catenin Pathway in Conventional Dendritic cells in Obesity-Induced Tissue Inflammation and insulin Resistance
  1042. A low fat diet ameliorates pathology but retains beneficial effects associated with CPT1b knockout in skeletal muscle
  1043. Antihyperglycemic and antioxidant effect of the total flavones of Potentilla kleiniana Wight et Arn. in streptozotocin induced diabetic rats.
  1044. The effects of high dietary doses of chromium (III) complex with propionic acid on nutritional and selected blood indices in healthy female rats
  1045. Type 2 diabetes treatment in the patient with obesity
  1046. Lower Leg Fat Depots Are Associated with Albuminuria Independently of Obesity, insulin Resistance, and Metabolic Syndrome (Korea National Health and …
  1047. Influence of resveratrol on endoplasmic reticulum stress and expression of adipokines in adipose tissues/adipocytes induced by high-calorie diet or palmitic acid
  1048. The Effect of Pituitary Gland Disorders on Glucose Metabolism: From Pathophysiology to Management
  1049. Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management
  1050. Therapeutic molecules against type 2 diabetes: What we have and what are we expecting?
  1051. Angiotensin II Mediated Regulation of Signal Transduction in Metabolic Syndrome and Cancer
  1052. Innate immune control of adipose tissue homeostasis
  1053. A novel metformin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes
  1054. Correlation between PAI-1, leptin and ferritin with HOMA in HIV/AIDS patients
  1055. Research progress on the role of gal-3 in cardio/cerebrovascular diseases
  1056. 36 Care of Geriatric Patients
  1057. From diabetes care to diabetes cure—the integration of systems biology, eHealth, and behavioral change
  1058. MicroRNA, proteins, and metabolites as novel biomarkers for prediabetes, diabetes, and related complications
  1059. Senescence alters PPARγ (Peroxisome Proliferator–Activated Receptor Gamma)-dependent fatty acid handling in human adipose tissue microvascular endothelial …
  1060. Lactobacillus pentosus S-PT84 prevents LPS-induced low-grade chronic inflammation in a C57BL/6J mouse model
  1061. Adipose tissue macrophage heterogeneity and the role of Tim4⁺ macrophages in lipid homeostasis
  1062. Promises of nanotherapeutics in obesity
  1063. Prevalence of Thyroid Dysfunction in a Chinese Population with Different Glucose Intolerance Status: A Community-Based Cross-Sectional Study
  1064. Investigation of C-glycosylated apigenin and luteolin derivatives’ effects on protein tyrosine phosphatase 1B inhibition with molecular and cellular approaches
  1065. Biochemical and Haematological Effects of the Leaf Extract of Newbouldia laevis in Alloxan-Induced Diabetic Rats
  1066. Thermal Injury
  1067. Dual Peroxisome Proliferator-activated Receptor Agonists
  1068. The Carotid Body a Common Denominator for Cardiovascular and Metabolic Dysfunction?
  1069. The right place for Sulphonylureas today: Part of ‘Review the Series: Implications of recent CVOTs in Type 2 diabetes mellitus’
  1070. The bioenergetics of inflammation: insights into obesity and type 2 diabetes
  1071. Physical exercise as an epigenetic modulator of brain plasticity and cognition
  1072. Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target
  1073. The EP3 Receptor/G z Signaling Axis as a Therapeutic Target for Diabetes and Cardiovascular Disease
  1074. Thyroid screening in prediabetes: Does it have any role?
  1075. Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
  1076. Care of Geriatric Patients
  1077. The Microvascular Control of insulin Action and insulin Resistance in Skeletal Muscle
  1078. Adipokines, inflammation, and insulin resistance in obesity
  1079. Hepatoprotective Effects of a Ruthenium (II) Schiff Base Complex in Rats with Diet-Induced Prediabetes
  1080. Dual-specificity phosphatases regulate mitogen-activated protein kinase signaling in adipocytes in response to inflammatory stress
  1081. Trigonella foenum-graceum (fenugreek) for Managemen of Diabetes
  1082. AICAR Influences AS160 Phosphorylation and Autophagy Induction via the GSK3β-TIP60-ULK1 Pathway
  1083. Pharmacological aspects of the safety of gliflozins
  1084. Epidemiology, risk factors across the spectrum of age-related metabolic diseases
  1085. The emerging therapeutic potential of nitro fatty acids and other Michael acceptor-containing drugs for the treatment of inflammation and cancer
  1086. Genetic variants influence the response of body composition and insulin resistance to dietary monounsaturated fatty acids consumption
  1087. Sobetirome: the past, present and questions about the future
  1088. Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules
  1089. Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin‐3 level
  1090. Western diet aggravates neuronal insult in post-traumatic brain injury: Proposed pathways for interplay
  1091. Impact of Drugs on Diabetes Risk and Glycemic Control
  1092. Connecting Pathway Errors in the insulin Signaling Cascade: The Molecular Link to Inflammation, Obesity, Cancer, and Alzheimer’s Disease
  1093. Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
  1094. Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease
  1095. Roles of galectin-3 in metabolic disorders and tumor cell metabolism
  1096. Metformin inhibits both oleic acid-induced and CB1R receptor agonist-induced lipid accumulation in Hep3B cells: The preliminary report
  1097. Serum ferritin correlates with liver fat in male adolescents with obesity
  1098. Metabolic Targets in Nonalcoholic Steatohepatitis: Treating the Disease at the Metabolic Root
  1099. Pharmacological Activation of Thyroid Hormone Receptors Elicits a Functional Conversion of White to Brown Fat
  1100. Combinations of regenerative medicine and Lab-on-a-chip systems: New hope to restoring the proper function of pancreatic islets in diabetes
  1101. Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology
  1102. The Effects of the N-hexane Fractions of Heinsia crinita Leaf Extract on Electrolyte Balance and Some Haematological Parameters of Alloxan-induced Diabetic Albino …
  1103. The effect of phase I therapy on the clinical parameters, VSC levels, and RBS levels in chronic periodontitis patients with diagnosed diabetes
  1104. Liver function as an engineering system
  1105. Abietane-type diterpenoids inhibit protein tyrosine phosphatases by stabilizing an inactive enzyme conformation
  1106. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: genesis of a wonder drug?
  1107. Androgen effect on body weight and behaviour of male and female rats: novel insight on the clinical value
  1108. Interleukin-4 retards liver fibrosis in Balb/C mice model of carbon tetra-chloride (CCl4)-associated with decreased CD80 and interleukin-12 expressions
  1109. Associatio n of Diabetes mellitus and Thyroid disorders: A metabolic prospective
  1110. The Secrets You Should Know About Sexual Medicine; Part One; Obesity and Sexual Dysfunction
  1111. iNOS as a metabolic enzyme under stress conditions
  1112. Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: a systematic review
  1113. Anti-hyperglycemic effect of aqueous extract of Juglans regia L. leaf (walnut leaf) on type 2 diabetic patients: A randomized controlled trial
  1114. Polycystic Ovarian Syndrome (PCOS) and Nutritional Supplementation©
  1115. Effect of fenugreek consumption with metformin treatment in improving plaque index in diabetic patients
  1116. Effect of JAK-STAT pathway in regulation of fatty liver hemorrhagic syndrome in chickens
  1117. 24 h pre-incubation of EA. hy926 cells with angiotensin II regulates insulin-dependent activation of eNOS in a concentration-dependent manner
  1118. The potential of artemisinins as anti-obesity agents via modulating the immune system
  1119. Modulation of VEGF signaling in a mouse model of diabetes by xanthohumol and 8‐prenylnaringenin: Unveiling the angiogenic paradox and metabolism interplay
  1120. Pattern and correlates of hypomagnesemia among subset of diabetes mellitus
  1121. Obesity and cancer metabolism: a perspective on interacting tumor–intrinsic and extrinsic factors
  1122. The molecular basis of hepatic de novo lipogenesis in insulin resistance
  1123. Interleukin-4 Retards Liver Fibrosis in Balb/C Mice Model of Carbon Tetra-Chloride (CCl
  1124. Deep multi-OMICs and multi-tissue characterization in a pre-and postprandial state in human volunteers: the GEMM family study research design
  1125. Hematoprotective and nephroprotective properties of ethanolic extract of Anthemis odontostephana Boiss in Streptozotocin-induced diabetic mice
  1126. ADIPOSE TISSUE-TARGETED STEM CELL TRANSPLANTATION FOR insulin RESISTANCE-RELATED CNS DEFICITS
  1127. Inhibition of Hypothalamic Inhibitor κB Kinase β/Nuclear Transcription Factor κB Pathway Attenuates Metabolism and Cardiac Dysfunction in Type 2 Diabetic Rats
  1128. The SERCA3 Pathway is Correlated to Optimal insulin Secretion in Pancreatic Cell Lines Derived From Type-2 Diabetic Patients
  1129. The SERCA3 Pathway is Correlated to Optimal insulin Secretion in Pancreatic Cell Lines Derived From Type-2 Diabetic Patients
  1130. insulin: its role in growth of fetus and child
  1131. Metabolic Diseases and Aging 17
  1132. Double lipoxygenation of polyunsaturated fatty acids of nutritional interest
  1133. Evaluation of micronutrient (zinc, magnesium, and copper) levels in serum and glycemic status after nonsurgical periodontal therapy in type 2 diabetic patients …
  1134. Investigating the Redox Properties of Two-Dimensional MoS2 Using Photoluminescence Spectroelectrochemistry and Scanning Electrochemical Cell Microscopy
  1135. Development of Microfluidic Platform to Study insulin Resistance
  1136. 2, 4 dinitrophenol as medicine
  1137. The role of Peroxisome Proliferator-Activated Receptors (PPAR) in immune responses
  1138. PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption
  1139. Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
  1140. Why do I treat my patients with mild hepatitis C?
  1141. Costus afer modulates the activities of glycolytic and gluconeogenic enzymes in streptozotocin induced diabetic rats
  1142. Periodontics and Oral-Systeric Relationships: Diabetes
  1143. Metabolic Diseases and Aging
  1144. Myocardial metabolism in heart failure: purinergic signalling and other metabolic concepts
  1145. Backbone resonance assignments of the catalytic and regulatory domains of Ca 2+/calmodulin-dependent protein kinase 1D
  1146. Inflammatory signaling and brown fat activity
  1147. Combined metformin and resveratrol confers protection against UVC-induced DNA damage in A549 lung cancer cells via modulation of cell cycle checkpoints …
  1148. Syringic acid improves oxidative stress and mitochondrial biogenesis in the liver of streptozotocin-induced diabetic rats
  1149. pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression
  1150. THR-ß agonism improves disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis
  1151. Adipose stem cells in obesity: challenges and opportunities
  1152. Performance enhancement drugs and sports supplements: A review of the evidence
  1153. Plaque imaging to refine indications for emerging lipid-lowering drugs
  1154. The START-domain proteins in intracellular lipid transport and beyond
  1155. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner
  1156. Obesity: current treatment and future horizons
  1157. Berberine ameliorates obesity-induced chronic inflammation through suppression of ER stress and promotion of macrophage M2 polarization at least partly via …
  1158. D-chiro inositol phosphoglycans in preeclampsia: where are we, where are we going?
  1159. Resistance training modulates the humoral inflammatory (but not the DNA methylation) profile of diabetic older adults using metformin
  1160. Hematoprotective and nephroprotective effects of Achillea millefolium aqueous extract in diabetic mice
  1161. Potential impact of Paracentrotus lividus extract on diabetic rat models induced by high fat diet/streptozotocin
  1162. Endothelial progenitor cells as pathogenetic and diagnostic factors, and potential targets for GLP-1 in combination with metabolic syndrome and chronic obstructive …
  1163. Red raspberries and their bioactive polyphenols: cardiometabolic and neuronal health links
  1164. Epigenetics and nutrition-related epidemics of metabolic diseases: Current perspectives and challenges
  1165. Nutraceutical prospective: The synergetic mechanism of action of inositols and resveratrol on metabolic syndrome
  1166. Diabetes & Obesity—Diabesity: A Genetic Curse or an Eating Hazard—How to Unmake the Mistake
  1167. Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases
  1168. Sulindac decreases basal-like mammary tumor burden and pro-inflammatory mediators in obese mice
  1169. A pharmacokinetic study of GC-1 delivery using a nanochannel membrane device
  1170. The effect of periodontal and prosthodontic therapy on glycemic control in patients with diabetes
  1171. Hydrogen sulfide signaling in mitochondria and disease
  1172. Synergistic Effects of Metformin and Cocoa Flavanol on Inflammatory and Oxidant Markers Induced by Carrageenan: Pathophysiological Approach
  1173. Metformin Revisited
  1174. Myocardial glucotoxicity: Mechanisms and potential therapeutic targets
  1175. 368 SECTION 2 Syndromes by Body System: The Gastrointestinal System
  1176. Metformin ameliorates the phenotype transition of peritoneal mesothelial cells and peritoneal fibrosis via a modulation of oxidative stress
  1177. Inhibition of the Renin–Angiotensin System: How Far Have We Come?
  1178. NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression
  1179. Mitochondrial Dynamics in the Brain Are Associated With Feeding, Glucose Homeostasis, and Whole-Body Metabolism
  1180. Diabetes and Periodontal Disease: A Two-Way Relationship
  1181. Identification of heme oxygenase-1 as a novel predictor of hematopoietic stem cell transplantation outcomes in acute leukemia
  1182. Olive Oil in Metabolic Syndrome
  1183. Identification of novel molecular mechan therapeutic strategy in cardiovascular disea
  1184. Evaluation of the therapeutic properties of a Ruthenium (ll) uracil-derived diimine complex on selected complications associated with diet-induced pre-diabetes.
  1185. Metabolic Bioactivity of Athrixia phylicoides
  1186. Jay Ian Lakkis and Matthew R. Weir
  1187. The mitochondrial Ca2+ uptake and the fine-tuning of aerobic metabolism
  1188. FACULTEIT GENEESKUNDE EN LEVENSWETENSCHAPPEN
  1189. Cellular acidosis triggers human MondoA transcriptional activity by driving mitochondrial ATP production
  1190. Inflammatory and oxidative stress markers in skeletal muscle of obese subjects
  1191. Research methodology for in vivo measurements of resting energy expenditure, daily body temperature, metabolic heat and non-viral tissue-specific gene therapy in …
  1192. Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes
  1193. Antihyperglycemic Effect of an Important Phytocompound-Phloretin on Streptozotocin Induced Diabetes: An Experimental Study
  1194. Estrogen signaling and UCP1: exploring mechanisms to improve metabolic health
  1195. Antioxidant potential of biflavonoid attenuates hyperglycemia by modulating the carbohydrate metabolic enzymes in high fat diet/streptozotocin induced diabetic rats
  1196. Impact of Chronic Periodontitis on Systemic Conditions: A Review
  1197. Determination of the antidiabetic chemical basis of Phellodendri Chinensis Cortex by integrating hepatic disposition in vivo and hepatic gluconeogenese inhibition in …
  1198. Pharma-nutritional properties of olive oil phenols. Transfer of new findings to human nutrition
  1199. Potential of Rasāhāra and Yoga in Treatment of Pre Diabetes-A Controlled Trial
  1200. Post Kidney Transplant: Obesity
  1201. Fundamental role of Warburg effect in various pathophysiological processes
  1202. Lipid (per) oxidation in mitochondria: an emerging target in the ageing process?
  1203. A metabolic inhibitory cocktail for grave cancers: metformin, pioglitazone and lithium combination in treatment of pancreatic cancer and glioblastoma multiforme
  1204. Chronic Passive Heat Exposure and Cardiometabolic Health in Obese Women with Polycystic Ovary Syndrome
  1205. Dr. Cimino’s Weight Loss Solution: The No Calorie Counting, No Exercise, Rapid Weight Loss Plan
  1206. Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists
  1207. Bornyl Derivatives of p-(Benzyloxy) Phenylpropionic Acid: In Vivo Evaluation of Antidiabetic Activity
  1208. Source and Composition in Amino Acid of Dietary Proteins in the Primary Prevention and Treatment of CKD
  1209. Using Metalloporphyrins to Preserve β Cell Mass and Inhibit Immune Responses in Diabetes
  1210. Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy
  1211. Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype
  1212. Mono-and Polyunsaturated Fatty Acids Counter Palmitate-Induced Mitochondrial Dysfunction in Rat Skeletal Muscle Cells
  1213. The Adipose Tissue
  1214. Pathophysiology of melanocortin receptors and their accessory proteins
  1215. Exercise and rehabilitation of older horses
  1216. An Evaluation of Alzheimer’s Disease-related Pathology in Two Different Models of Diabetes in Immune-challenged Mice
  1217. G protein-coupled receptors as targets for improving beta-cell function in acute and chronic conditions of glucose intolerance
  1218. Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection
  1219. Determining the Physiological Contribution of Adipocyte Subpopulations
  1220. Effects of non-surgical periodontal therapy on plasma level of reactive oxygen metabolites and glycemic status in type-2 diabetic patients with chronic …
  1221. The fructose-2, 6-bisphosphatase TIGAR suppresses NF-κB signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC
  1222. Impact of Metabolic Surgery in Cancer Prevention/Impacto da Cirurgia Metabólica na Prevenção de Cancro
  1223. Metabolic acidosis of chronic kidney disease
  1224. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
  1225. The multifaceted role of eosinophils in adipose tissue: from metabolism to allergy
  1226. Epistemic modals in academic English
  1227. β-Arrestin based receptor signaling paradigms: potential therapeutic targets for complex age-related disorders
  1228. Endocrine-disrupting chemicals and fatty liver disease
  1229. Alteration of cardiolipin-dependent mitochondrial coupling in muscle protects against obesity
  1230. Anti-Hyperglycemic and Anti-Oxidant Activities of Ethanolic Extract of Lantana Camara Leaves
  1231. Recent advances in c-Jun N-terminal kinase (JNK) inhibitors
  1232. 12 Metabolic Interventions
  1233. Determining the role of pancreatic alpha-cell autophagy in intra-cellular glucagon turnover and its modulation as an anti-diabetic therapy.
  1234. The Maladaptive Response of Adipose Tissue to High Fat Diet Feeding
  1235. Public health nutrition intervention to enhance healthy eating and lifestyle modification among Lebanese women with Polycystic Ovarian Syndrome
  1236. Expression of thyroglobulin by regulatory T cells in thyroid tissue
  1237. The Effect of the MNRI Method on Neurotransmitter Biomarkers of Individuals with Neurodevelopmental Disorders
  1238. Investigation of S1P and S1P Signaling in Adipocytes and Adipocyte-Breast Cancer Cell Interaction
  1239. Pharmacological actions of glucagon-like peptide-1, gastric inhibitory polypeptide, and glucagon
  1240. Identification of Shared Molecular Pathways and Networks between Alzheimer’s Disease and Type 2 Diabetes
  1241. Diabetes Risk Status and Physical Activity in Pregnant Women: US BRFSS 2011, 2013, 2015, 2017
  1242. Dietary interventions in C57BL/6 mice and their interplay with selected metabolic and genetic parameters
  1243. Polyphenols in diabetic vascular complications: from mechanisms to identification of therapeutic targets
  1244. Microbiota reprogramming for treatment of alcohol-related liver disease
  1245. Tetrahydro-iso-alpha acids antagonize estrogen receptor alpha activity in MCF-7 breast cancer cells
  1246. The innate immune kinase IKKε as a novel regulator of PSAT1 and serine metabolism
  1247. Burn Shock and Resuscitation: Many Priorities, One Goal
  1248. Protective effect of EX-527 against high-fat diet-induced diabetic nephropathy in Zucker rats
  1249. Transcriptional and translational regulators: Roles in development and function of innate-like and adaptive regulatory T cells
  1250. Metabolic Therapy for Age-Dependent Impaired Wound Healing
  1251. Complete nurse’s guide to diabetes care
  1252. Characterisation of the relationship between Heme-oxygenase-1 and adiponectin
  1253. Effect of dietary soy protein and oils containing omega-3 fatty acids on disease and renal oxylipins in polycystic kidney disease
  1254. The Leucine Factor Diet: The Scientifically-Proven Approach to Combat Sugar, Burn Fat and Build Muscle
  1255. Systems Biology Analysis of the Fate and Effects of Endocrine Disrupting Chemicals in Models of Adipose Tissue and the Gut Microbiota
  1256. How to Live: The groundbreaking lifestyle guide to keep you healthy, fit and free of illness
  1257. Effects of Synthetic Ligands on Heterodimer Pairs Regarding Full-Length Human PPARa, RXRa and LXRa
  1258. Impact of n-3 Polyunsaturated Fatty Acids on Adipose Tissue Inflammation and Metabolic Control in Severely Obese Patients
  1259. Current endoscopic/laparoscopic bariatric procedures
  1260. A History of Flexible Gastrointestinal Endoscopy
  1261. Kick Diabetes Essentials: The Diet and Lifestyle Guide
  1262. ROLE OF THE LONG PENTRAXIN 3 (PTX3) IN CARDIOMETABOLIC DISEASES
  1263. Metformin Pharmacogenomics: Functional Genomics of CDC25b and TPD54 Regulation of Metformin Anticancer Response in Breast Cancer
  1264. The Impact of Obesity on Proteins Involved in Drug Disposition
  1265. IKK Family Kinases Regulate Cell Growth, Metabolism and Autophagy by Phosphorylation of Key Substrates
  1266. The Aryl Hydrocarbon Receptor and Diet-Induced Obesity: An Investigation of How the Canonical Toxicant Receptor Modulates the Obese State via Activation and …
  1267. Prognostic Biomarkers of Periodontal Disease
  1268. Breast cancer associated muscle fatigue: Novel targets to improve survival and quality of life
  1269. The Banting Solution: Your low-carb guide to permanent weight loss
  1270. Defining the Role of Autophagy Kinase ULK1 Signaling in Therapeutic Response of Tuberous Sclerosis Complex to mTOR Inhibitors
  1271. RIBOSWITCH: AN AREA OF NOVEL BREAKTHROUGH IN RNA WORLD
  1272. DNA Methylation Dynamics and Epigenetic Memory in Highly Metabolic Mammalian Organs
  1273. Your Body in Balance: The New Science of Food, Hormones, and Health
  1274. Study of the role of the carotid sinus nerve in inflammation: electrostimulation of the carotid sinus nerve in mice attenuates inflammation by acting on the hypothalamic …
  1275. Analysis of secondary metabolism in marine Actinobacteria: searching for novel compounds
  1276. Mechanisms of CD4+ regulatory T cell heterogeneity in health and disease
  1277. Endoscopy, An Issue of Surgical Clinics, E-Book
  1278. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure
  1279. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation
  1280. DHA at nutritional doses restores insulin sensitivity in skeletal muscle by preventing lipotoxicity and inflammation
  1281. insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity
  1282. Hepatic overexpression of a dominant negative form of raptor enhances Akt phosphorylation and restores insulin sensitivity in K/KAy mice
  1283. ApoA-1 mimetic restores adiponectin expression and insulin sensitivity independent of changes in body weight in female obese mice
  1284. insulin resistance associated to obesity: the link TNF-alpha
  1285. Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver
  1286. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1
  1287. Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes
  1288. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients
  1289. Exercise-induced increase in muscle insulin sensitivity
  1290. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise
  1291. Effect of the volume and intensity of exercise training on insulin sensitivity
  1292. Reversal of diet‐induced insulin resistance with a single bout of exercise in the rat: the role of PTP1B and IRS‐1 serine phosphorylation
  1293. Effect of calorie restriction with or without exercise on insulin sensitivity, β-cell function, fat cell size, and ectopic lipid in overweight subjects
  1294. Acute physical exercise reverses S‐nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet‐induced obese Wistar rats
  1295. Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
  1296. Imatinib mesylate improves insulin sensitivity and glucose disposal rates in rats fed a high-fat diet
  1297. AMPK and exercise: glucose uptake and insulin sensitivity
  1298. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly
  1299. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
  1300. (-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice
  1301. Irs1 serine 307 promotes insulin sensitivity in mice
  1302. Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet–fed mice
  1303. Increased GLUT-4 translocation mediates enhanced insulin sensitivity of muscle glucose transport after exercise
  1304. Acute oxidative stress can reverse insulin resistance by inactivation of cytoplasmic JNK
  1305. Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements
  1306. Bilirubin increases insulin sensitivity by regulating cholesterol metabolism, adipokines and PPARγ levels
  1307. Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15
  1308. Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly
  1309. Vagotomy diminishes obesity in cafeteria rats by decreasing cholinergic potentiation of insulin release
  1310. Acute exercise reverses aged-induced impairments in insulin signaling in rodent skeletal muscle
  1311. The cannabinoid Δ 9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
  1312. Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy
  1313. Chronic caffeine intake reverses age-induced insulin resistance in the rat: effect on skeletal muscle Glut4 transporters and AMPK activity
  1314. Effect of physical exercise on insulin sensitivity and responsiveness to insulin in humans
  1315. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy
  1316. Iron overload and non-alcoholic fatty liver disease.
  1317. Electrical vs manual acupuncture stimulation in a rat model of polycystic ovary syndrome: different effects on muscle and fat tissue insulin signaling
  1318. Exercise training prevents maturation-induced decrease in insulin sensitivity
  1319. Preconception diet or exercise intervention in obese fathers normalizes sperm microRNA profile and metabolic syndrome in female offspring
  1320. Influence of commonly employed resistance exercise protocols on circulating IL-6 and indices of insulin sensitivity
  1321. Impact of octreotide, a long‐acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly
  1322. Captopril restores insulin sensitivity in ob/ob Mouse Hearts
  1323. Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome
  1324. The phosphatidylinositol/AKT/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo
  1325. Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy …
  1326. Loss of PDGF-B activity increases hepatic vascular permeability and enhances insulin sensitivity
  1327. Growth hormone replacement therapy and insulin sensitivity
  1328. Effect of physical activity on insulin resistance, inflammation and oxidative stress in diabetes mellitus
  1329. Galectin-12 enhances inflammation by promoting M1 polarization of macrophages and reduces insulin sensitivity in adipocytes
  1330. Prolonged increase in insulin-stimulated glucose transport in muscle after exercise
  1331. Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes
  1332. Alcohol consumption promotes mammary tumor growth and insulin sensitivity
  1333. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic
  1334. Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients
  1335. Resistin and obesity-associated insulin resistance
  1336. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults
  1337. Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 …
  1338. Glucose and fat metabolism in acromegaly: from mice models to patient care
  1339. Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism
  1340. Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats
  1341. Comparison among different insulin sensitivity indices in obese patients
  1342. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis
  1343. The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus
  1344. Prowashonupana barley dietary fibre reduces body fat and increases insulin sensitivity in Caenorhabditis elegans model
  1345. L-4f Restores insulin sensitivity And Attenuates Adiposity In Diabetic Obese Mice By Increasing Adiponectin, pAMPK And pAKT Levels And Decreasing Nuclear …
  1346. Effects of growth hormone on lipid metabolism in humans
  1347. Marked insulin resistance in obese spontaneously hypertensive rat adipocytes is ameliorated by in vivo but not in vitro treatment with moxonidine
  1348. Treating diabetes by blocking a vascular growth factor
  1349. Improvement of insulin response in the streptozotocin model of insulin-dependent diabetes mellitus. insulin response with and without a long-acting insulin treatment
  1350. Activation of nuclear receptor NR5A2 increases Glut4 expression and glucose metabolism in muscle cells
  1351. The sensory nitrergic nature of the hepatic insulin sensitizing substance mechanism in conscious rabbits
  1352. New insight into the mechanism by which acute physical exercise ameliorates insulin resistance
  1353. The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross …
  1354. PAQRs: a counteracting force to ceramides?
  1355. Stevioside ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by downregulating the NF-κB pathway
  1356. Heat shock protein 90 (HSP90) inhibitors activate the heat shock factor 1 (HSF1) stress response pathway and improve glucose regulation in diabetic mice
  1357. The role of aldosterone in cardiovascular disease in people with diabetes and hypertension: an update
  1358. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy
  1359. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM
  1360. Propranolol improves impaired hepatic phosphatidylinositol 3-kinase/akt signaling after burn injury
  1361. Invited review: Effects of acute exercise and exercise training on insulin resistance
  1362. Central leptin acutely reverses diet-induced hepatic insulin resistance
  1363. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1α: implications for metabolic disease
  1364. Effects of fasting and refeeding on insulin receptors and glucose metabolism in rat adipocytes
  1365. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone
  1366. Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysis
  1367. The forkhead transcription factor Foxo1 regulates adipocyte differentiation
  1368. Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue
  1369. Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice
  1370. Caffeic acid phenethyl ester regulates PPAR’s levels in stem cells-derived adipocytes
  1371. The frequency of daily ethanol consumption influences the effect of ethanol on insulin sensitivity in rats fed a high-fat diet
  1372. Early intensive insulin treatment for induction of long‐term glycaemic control in type 2 diabetes
  1373. insulin release, peripheral insulin resistance and muscle function in protein malnutrition: a role of tricarboxylic acid cycle anaplerosis
  1374. 1-Deoxynojirimycin isolated from a Bacillus subtilis stimulates adiponectin and GLUT4 expressions in 3T3-L1 adipocytes
  1375. Amyloid-β induces hepatic insulin resistance in vivo via JAK2
  1376. Muscle long‐chain acyl CoA esters and insulin resistance
  1377. CXCL5 drives obesity to diabetes, and further
  1378. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins
  1379. From excess adiposity to insulin resistance: the role of free fatty acids
  1380. Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β) improves skeletal muscle mitochondrial function and insulin sensitivity
  1381. 12 insulin treatment of non-insulin-dependent diabetes mellitus
  1382. Involvement of the PA28γ-dependent pathway in insulin resistance induced by hepatitis C virus core protein
  1383. The osteoblast: an insulin target cell controlling glucose homeostasis
  1384. High dietary protein intake, reducing or eliciting insulin resistance?
  1385. Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins
  1386. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance
  1387. Knockdown of LYRM1 rescues insulin resistance and mitochondrial dysfunction induced by FCCP in 3T3-L1 adipocytes
  1388. Effects of vaspin, chemerin and omentin-1 on feeding behavior and hypothalamic peptide gene expression in the rat
  1389. Effect of insulin on glucose transport and metabolism in adipose tissue and skeletal muscle of hypophysectomized rats
  1390. Antihypertensive drugs and insulin resistance in obesity
  1391. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
  1392. Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice
  1393. Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers
  1394. Analysis of FOXO1A as a candidate gene for type 2 diabetes
  1395. Adipocyte JAK2 mediates hepatic insulin sensitivity and the diabetogenic action of Growth Hormone
  1396. Sex steroids and insulin resistance
  1397. Citrus polymethoxylated flavones improve lipid and glucose homeostasis and modulate adipocytokines in fructose-induced insulin resistant hamsters
  1398. Lipid-induced metabolic dysfunction in skeletal muscle
  1399. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation
  1400. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis
  1401. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults
  1402. Diacylglycerol-mediated insulin resistance
  1403. Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats
  1404. Glycosphingolipids and insulin resistance
  1405. The adrenal and the metabolic syndrome
  1406. Growth hormone and insulin resistance
  1407. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
  1408. Serum resistin concentrations in growth hormone–deficient children during growth hormone replacement therapy
  1409. Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle
  1410. Metabolic Mechanisms of Muscle insulin Resistance
  1411. Comment on: Harrison et al. β-Cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care 2012; 35: 1406–1412
  1412. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults
  1413. Adiponectin levels during low‐and high‐fat eucaloric diets in lean and obese women
  1414. 0341: AMPK exerts an insulin-sensitizing effect on cardiac glucose uptake by multiple molecular mechanisms including cytoskeleton reorganization
  1415. Sphingolipids and insulin resistance: the five Ws
  1416. Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats
  1417. insulin RESISTANCE IN THE HORSE
  1418. The metabolic syndrome, IGF-1, and insulin action
  1419. Evaluation of the Effect of Dehydroepiandrostrone (DHEA) on insulin sensitivity in IGT Patients
  1420. Effects of single bout of very high-intensity exercise on metabolic health biomarkers in overweight/obese sedentary men
  1421. Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
  1422. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK
  1423. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice
  1424. Effect of growth hormone (GH) on fasting and postprandial metabolism in GH deficiency
  1425. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and …
  1426. Postprandial but not fasting insulin resistance is an early identifier of dysmetabolism in overweight subjects
  1427. PEDF-induced alteration of metabolism leading to insulin resistance
  1428. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid–induced ceramide biosynthesis in mice
  1429. Ceramides–lipotoxic inducers of metabolic disorders
  1430. Attenuation of insulin-mediated pressor effect and nitric oxide release in rats with fructose-induced insulin resistance
  1431. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans
  1432. Skeletal muscle as a metabolic target for growth hormone
  1433. Effects of DHEA on diabetes mellitus
  1434. Incretin-based therapies for type 2 diabetes mellitus: effects on insulin resistance
  1435. Improvement of glucose homeostasis after weight loss in obese children
  1436. Serum N-Acetyl-β-D-Glucosaminidase, Activity in a Genetic Rat Model of Non-insulin-Dependent Diabetes Mellitus
  1437. Endoplasmic reticulum stress and hepatic lipid metabolism
  1438. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes
  1439. Impact of different bariatric surgical procedures on insulin action and β-cell function in type 2 diabetes
  1440. A single dose of metformin improves whole body insulin sensitivity and alters cellular redox state in skeletal muscle of Zucker fa/fa rats
  1441. Anti-Ageing Cure
  1442. Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributions in drug-naive subjects with type 2 diabetes
  1443. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer)
  1444. Somatropin and Glucose Homeostasis
  1445. The Role of Lipid Metabolism in Altered insulin sensitivity in Endocrine Disease
  1446. Inflammation, dyslipidaemia, diabetes and PPars: pharmacological interest of dual PPARα and PPARγ agonists
  1447. Estrogen deprivation in primate pregnancy leads to insulin resistance in offspring
  1448. A ceramide-centric view of insulin resistance
  1449. Body Composition in Adolescents with Type 1 Diabetes: Aspects of Glycaemic Control and insulin sensitivity
  1450. Effects of growth hormone on glucose and fat metabolism in human subjects
  1451. Glycosphingolipids and insulin resistance
  1452. Biozentrum, Div. of Pharmacology/Neurobiology, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland
  1453. TNF-α as an Adipokine
  1454. The clinical relevance of pancreatic B-cell hyperplasia, hyperinsulinism and insulin ininsulin sensitivity in non-insulin dependent diabetes mellitus
  1455. Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones
  1456. Pioglitazone enhances expression of genes involved in mitochondrial oxidative metabolism in skeletal muscle of women with polycystic ovary syndrome …
  1457. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
  1458. Obesity, blood pressure, and renal sodium handling
  1459. Hepatic Bax inhibitor-1 inhibits IRE1α and protects from obesity-associated insulin resistance and glucose intolerance
  1460. HIV-associated lipodystrophy syndrome
  1461. Comparison of two different sprint interval training work-to-rest ratios on acute inflammatory responses
  1462. Red wine mimic can fight diabetes
  1463. ORALS: DISRUPTION IN SIGNALING LEADING TO insulin RESISTANCE
  1464. The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance
  1465. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression
  1466. Effect Of Vasodilatory β‐Adrenoceptor Blockers On Cardiovascular Haemodynamics In Anaesthetized Rats
  1467. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics
  1468. Patterns of glucose and lipid abnormalities in black NIDDM subjects
  1469. The association between blood pressure and glucosylceramides in spontaneously hypertensive rats
  1470. Ganglioside GM3 as a gatekeeper of obesity-associated insulin resistance: Evidence and mechanisms
  1471. Glucose Toxicity and insulin Resistance in NIDDM
  1472. Estrogen: an emerging regulator of insulin action and mitochondrial function
  1473. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients
  1474. Diets and nonalcoholic fatty liver disease: the good and the bad
  1475. Artificial selection for high-capacity endurance running is protective against high-fat diet-induced insulin resistance
  1476. insulin resistance: A new consequence of altered carotid body chemoreflex?
  1477. Invited review: effect of acute exercise on insulin signaling and action in humans
  1478. Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in middle-aged men
  1479. Ceramides and glucosylceramides are independent antagonists of insulin signaling
  1480. Growth hormone and glucose homeostasis
  1481. Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans
  1482. Prevention and Reversal of Diabetes
  1483. The effect of exercise and insulin on AS160 phosphorylation and 14-3-3 binding capacity in human skeletal muscle
  1484. Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats
  1485. The impact of adipose tissue on insulin resistance in acromegaly
  1486. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress
  1487. Ceramide kinase deficiency improves diet-induced obesity and insulin resistance
  1488. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes
  1489. Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes
  1490. Role of macrophage tissue infiltration in obesity and insulin resistance
  1491. Oat consumption reduced intestinal fat deposition and improved health span in Caenorhabditis elegans model
  1492. Brain adipocytokine action and metabolic regulation
  1493. Physical inactivity, insulin resistance, and the oxidative-inflammatory loop
  1494. Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects
  1495. insulin-like growth factors and insulin: at the crossroad between tumor development and longevity
  1496. Glucose Toxicity and insulin Resistance
  1497. The acute and residual effect of a single exercise session on meal glucose tolerance in sedentary young adults
  1498. Mouse models of insulin resistance
  1499. Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase
  1500. TWEAK prevents TNF-α-induced insulin resistance through PP2A activation in human adipocytes
  1501. insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats
  1502. Membrane microdomains and insulin resistance
  1503. Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy
  1504. IRS proteins and the common path to diabetes
  1505. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice
  1506. Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium
  1507. Transplantation of wild-type white adipose tissue normalizes metabolic, immune and inflammatory alterations in leptin-deficient ob/ob mice
  1508. Metformin Suppresses Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-+Leprdb/+Leprdb Mice
  1509. Effect of exercise training on A‐FABP, lipocalin‐2 and RBP4 levels in obese women
  1510. Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
  1511. Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response
  1512. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism
  1513. N− 3PUFA differentially modulate palmitate-induced lipotoxicity through alterations of its metabolism in C2C12 muscle cells
  1514. Living without insulin: the role of leptin signaling in the hypothalamus
  1515. The twists and turns of sphingolipid pathway in glucose regulation
  1516. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance
  1517. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion
  1518. Novel insulin sensitizer modulates nutrient sensing pathways and maintains β-cell phenotype in human islets
  1519. Novel mechanisms of insulin resistance and weight gain in diet induced obesity
  1520. JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
  1521. An anti-aging drug today: from senescence-promoting genes to anti-aging pill
  1522. An ascochlorin derivative, AS-6, potentiates insulin action in streptozotocin diabetic mice and rats
  1523. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism
  1524. Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double …
  1525. Adipocytes as regulators of energy balance and glucose homeostasis
  1526. Bcl10 links saturated fat overnutrition with hepatocellular NF-κB activation and insulin resistance
  1527. Thermogenesis and related metabolic targets in anti-diabetic therapy
  1528. Is reactivation of autophagy a possible therapeutic solution for obesity and metabolic syndrome?
  1529. Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training
  1530. Enhanced glucose metabolism in cultured human skeletal muscle after Roux-en-Y gastric bypass surgery
  1531. Toll‐like receptors 2 and 4 impair insulin‐mediated brain activity by interleukin‐6 and osteopontin and alter sleep architecture
  1532. Impact of divergent effects of astaxanthin on insulin signaling in L6 cells
  1533. Clodronate Liposomes Improve Metabolic Profile and Reduce Visceral Adipose Macrophage Content in
  1534. insulin Resistance and the Metabolic Syndrome
  1535. RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27
  1536. Self-adjusting synthetic gene circuit for correcting insulin resistance
  1537. Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling
  1538. Role of endogenous androgen against insulin resistance and athero-sclerosis in men with type 2 diabetes
  1539. T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance
  1540. In vivo mutagenesis of the insulin receptor
  1541. Hypertension–a visceral afferent problem
  1542. Hepatic ERK activity plays a role in energy metabolism
  1543. Prior exercise increases phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle
  1544. insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1
  1545. Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome
  1546. Gangliosides in cell recognition and membrane protein regulation
  1547. Effects of DHA-enriched fish oil on monocyte/macrophage activation marker sCD163, asymmetric dimethyl arginine, and insulin resistance in type 2 diabetic patients
  1548. insulin-sensitising agents: beyond thiazolidinediones
  1549. The Short-term Effects of insulin, Metformin and insulin-Metformin Combination on the Liver Morphology in High Fat Diet/Streptozotocin Induced Diabetic Albino …
  1550. Neutralizing Th2 inflammation in neonatal islets prevents β-cell failure in adult IUGR rats
  1551. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to …
  1552. Phosphorylation of IRS proteins, insulin action, and insulin resistance
  1553. Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys?
  1554. Anti-diabetic effect of 3-hydroxy-2-naphthoic acid, an endoplasmic reticulum stress-reducing chemical chaperone
  1555. Exercise training increases intramyocellular lipid and oxidative capacity in older adults
  1556. Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism
  1557. Sensing’the link between type 1 and type 2 diabetes
  1558. Effect of GH on human skeletal muscle lipid metabolism in GH deficiency
  1559. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia
  1560. Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver
  1561. Effects of GH in human muscle and fat
  1562. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification
  1563. Validation of anti-aging drugs by treating age-related diseases
  1564. Dehydroepiandrosterone increases β-cell mass and improves the glucose-induced insulin secretion by pancreatic islets from aged rats
  1565. Loss of protein tyrosine phosphatase 1B increases IGF-I receptor tyrosine phosphorylation but does not rescue retinal defects in IRS2-deficient mice
  1566. Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma
  1567. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis
  1568. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways
  1569. One bout of exercise alters free-living postprandial glycemia in type 2 diabetes
  1570. Maternal breastfeeding history and Alzheimer’s disease risk
  1571. Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars
  1572. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s disease
  1573. mTOR and the control of whole body metabolism
  1574. The metabolic syndrome as a vicious cycle: does obesity beget obesity?
  1575. Silencing CCR2 in macrophages alleviates adipose tissue inflammation and the associated metabolic syndrome in dietary obese mice
  1576. Early intranasal insulin therapy halts progression of neurodegeneration: progress in Alzheimer’s disease therapeutics
  1577. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
  1578. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders
  1579. Hypothalamic inflammation in the control of metabolic function
  1580. Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice
  1581. Metabolic consequences of androgen deprivation therapy for prostate cancer
  1582. Endocrine, metabolic, and immunologic components of HIV infection
  1583. Fasting-induced lipolysis and hypothalamic insulin signaling are regulated by neuronal glucosylceramide synthase
  1584. GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus
  1585. Molecular links between obesity and cardiovascular disease
  1586. Sensitization by insulin of the anaphylactoid inflammation in rats
  1587. The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM)
  1588. An explanation of the Equine Metabolic Syndrome, insulin resistance and the risk of laminitis
  1589. Effects of DHEA on metabolic and endocrine functions of adipose tissue
  1590. EPA prevents fat mass expansion and metabolic disturbances in mice fed with a Western diet
  1591. Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells.
  1592. Metformin: actions and indications for use in non-insulin-dependent diabetes mellitus
  1593. Effects of clenbuterol on insulin resistance in conscious obese Zucker rats
  1594. Ganglioside GM1 contributes to the state of insulin resistance in senescent human arterial endothelial cells
  1595. The impact of Heat Shock Protein 72 expression on mitochondrial function and insulin action
  1596. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes
  1597. insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load
  1598. Influence of endurance training on central sympathetic outflow to skeletal muscle in response to a mixed meal
  1599. Dietary antioxidants and glucose metabolism
  1600. Potential Mechanisms for Amelioration of Type 2 Diabetes Following Bariatric Surgery
  1601. Current and emerging aspects of diabetes mellitus in acromegaly
  1602. Androgen deficiency and mitochondrial dysfunction: implications for fatigue, muscle dysfunction, insulin resistance, diabetes, and cardiovascular disease
  1603. Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKCζ) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS) 1 …
  1604. The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis
  1605. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis
  1606. GH replacement causing acute hyperglycaemia and ketonuria in a type 1 diabetic patient
  1607. Sphingolipids: the nexus between Gaucher disease and insulin resistance
  1608. insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells
  1609. Long-term ethanol exposure inhibits glucose transporter 4 expression via an AMPK-dependent pathway in adipocytes
  1610. The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes
  1611. insulin down-regulates resistin mRNA through the synthesis of protein (s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes
  1612. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial
  1613. insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure
  1614. Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentrations in women with type 2 diabetes
  1615. Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity
  1616. Caffeine, insulin resistance, and hypertension
  1617. insulin receptor knockout mice
  1618. Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes
  1619. Treatment of non-alcoholic fatty liver disease
  1620. Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation
  1621. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome
  1622. Serum dehydroepiandrosterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes
  1623. Docosahexaenoic acid, inflammation, and bacterial dysbiosis in relation to periodontal disease, inflammatory bowel disease, and the metabolic syndrome
  1624. Adiponectin and high-density lipoprotein: a metabolic association through thick and thin
  1625. Leptin opposes insulin‘s effects on fatty acid partitioning in muscles isolated from obese ob/obmice
  1626. Comparative proteomic study of fatty acid-treated myoblasts reveals role of Cox-2 in palmitate-induced insulin resistance
  1627. Interactions of exercise training and α-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats
  1628. Dehydroepiandrosterone Suppresses Elevated Hepatic Glucose-6-phosphatase mRNA Level in C57BL/KsJ-db/db Mice
  1629. Targeting the AMPK pathway for the treatment of Type 2 diabetes
  1630. The role of organelle stresses in diabetes mellitus and obesity: implication for treatment
  1631. The influence of alpha-tocopherol supplementation on plasma concentration of this vitamin and insulin in sedentary or physically trained rats
  1632. Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes: a possible link …
  1633. Management of gestational diabetes
  1634. Assessment of partially deoxygenated deoxynojirimycin derivatives as glucosylceramide synthase inhibitors
  1635. Hepatic steatosis: a benign disease or a silent killer
  1636. insulin resistance, inflammation, and the IKK/IκB/NF-κB pathway
  1637. Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion
  1638. Consequences of growth hormone deficiency for intermediary metabolism and effects of replacement
  1639. Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury
  1640. AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
  1641. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats
  1642. Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors
  1643. Resistin mediates tomato and broccoli extract effects on glucose homeostasis in high fat diet-induced obesity in rats
  1644. ELEVATED INTERLUKIN-6 LEVELS AS A CONSEQUENCE, NOT THE CAUSE OF OBESITY AND insulin RESISTANCE
  1645. Changes of serum retinol binding protein 4 levels following 8 weeks moderate aerobic exercise
  1646. Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease …
  1647. Effects of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro
  1648. Gone with the Wnts: β-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism
  1649. Long-chain polyunsaturated fatty acids amend palmitate-induced inflammation and insulin resistance in mouse C2C12 myotubes
  1650. Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women
  1651. insulin resistance, inflammation, and the IKK/IkB/NF-kB pathway
  1652. Total and high-molecular-weight adiponectin and risk of incident diabetes in older people
  1653. New mechanisms by which physical exercise improves insulin resistance in the skeletal muscle
  1654. Adrenal androgens and aging
  1655. An Antiinflammatory and Reactive Oxygen Species Suppressive Effects of an Extract of Polygonum Cuspidatum Containing Resveratrol
  1656. Metabolomics applied to diabetes research: moving from information to knowledge
  1657. AMP-activated protein kinase and metabolic control
  1658. Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
  1659. Immune cell crosstalk in obesity: a key role for costimulation?
  1660. A safety evaluation of canagliflozin: a first-in-class treatment for type 2 diabetes
  1661. Dehydroepiandrosterone (DHEA)—a precursor steroid or an active hormone in human physiology (CME)
  1662. The role of the angiotensin system in cardiac glucose homeostasis
  1663. Glycogen synthase kinase-3 and mammalian target of rapamycin pathways contribute to DNA synthesis, cell cycle progression, and proliferation in human islets
  1664. A HaloTag-based small molecule microarray screening methodology with increased insulin sensitivity and multiplex capabilities
  1665. An insulin receptor peptide (1135-1156) stimulates guanosine 5′-[γ-thio] triphosphate binding to the 67 kDa G-protein associated with the insulin receptor
  1666. Identification of ganglioside GM3 molecular species in human serum associated with risk factors of metabolic syndrome
  1667. Adiponectin, leptin, and erythrocyte sodium/lithium countertransport activity, but not resistin, are related to glucose metabolism in growth hormone-deficient adults
  1668. Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women
  1669. Diethyl Hexyl Phthalate (DEHP) is associated with insulin resistance in adipose tissue of male rat: Protective role of antioxidant vitamins (C & E)
  1670. Effects of 8 weeks high intensity aerobic exercise on serum retinol binding protein 4 levels in female athletes
  1671. The adipokines resistin, leptin, PAI-1 and RBP4 induce degradation of IRS-1 in megakaryocytes and produc-tion of insulin-resistant platelets
  1672. Postdinner resistance exercise improves postprandial risk factors more effectively than predinner resistance exercise in patients with type 2 diabetes
  1673. Skeletal muscle lipid metabolism with obesity
  1674. The role of atypical and conventional PKC in dehydroepiandrosterone-induced glucose uptake and dexamethasone-induced insulin resistance
  1675. APPL1: role in adiponectin signaling and beyond
  1676. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPARγ
  1677. PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
  1678. Smoking and diabetes
  1679. 7 insulin action and substrate competition
  1680. Adipose tissue hypoxia and low-grade inflammation: a possible mechanism for ethanol-related glucose intolerance?
  1681. OPE WO OD
  1682. Fibroblast growth factor 21 as an emerging therapeutic target for type 2 diabetes mellitus
  1683. Dehydroepiandrosterone increases b-cell mass and improves the glucose-induced insulin secretion by pancreatic islets from aged rats
  1684. Aspartame downregulates 3T3-L1 differentiation
  1685. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy
  1686. Regulation of β‐cell mass and function by the Akt/protein kinase B signalling pathway
  1687. Effect of dehydroepiandrosterone administration on recovery from mix-type exercise training-induced muscle damage
  1688. Type II SOCS as a feedback repressor for GH-induced Igf1 expression in carp hepatocytes
  1689. As a matter of fat
  1690. The aging rodent: insulin resistance, obesity, and metabolic compensation
  1691. Metabolic Effects of Omega-3 Long-Chain Polyunsaturated Fatty Acids
  1692. The insulin growth factor system and nutrition in adulthood and aging
  1693. The role of glycosphingolipids in insulin signaling and lipid metabolism
  1694. Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock
  1695. Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet
  1696. insulin and GH Signaling in Human Skeletal Muscle In
  1697. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery
  1698. The peroxide dilemma: opposing and mediating insulin action
  1699. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity
  1700. Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice
  1701. Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells
  1702. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation
  1703. insulin as an anti-inflammatory and antiatherosclerotic hormone
  1704. Facilitative glucose transporters
  1705. Fisetin up-regulates the expression of adiponectin in 3T3-L1 adipocytes via the activation of silent mating type information regulation 2 homologue 1 (SIRT1) …
  1706. GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cure
  1707. The management of adult growth hormone deficiency syndrome
  1708. Adipose tissue: an endocrine organ playing a role in metabolic regulation
  1709. Impact of diabetes mellitus on lymphocyte GRK 2 protein levels in patients with heart failure
  1710. Environmental determinants of polycystic ovary syndrome
  1711. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes
  1712. Impaired glucose metabolism and reduced insulin clearance in elderly hypertensives
  1713. A role for sphingolipids in the pathophysiology of obesity-induced inflammation
  1714. Effects of physical training with different intensities of effort on lipid metabolism in rats submitted to the neonatal application of alloxan
  1715. Insights and Future Directions
  1716. Journal of the International Bariatric Club
  1717. Experimental models of high fat obesity and leucine supplementation
  1718. Glycosphingolipids and kidney disease
  1719. Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment
  1720. Disorders of glucose metabolism in the context of human immunodeficiency virus infection
  1721. A complex role for adipose tissue macrophages
  1722. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress
  1723. Diethyl hexyl phthalate-induced changes in insulin signaling molecules and the protective role of antioxidant vitamins in gastrocnemius muscle of adult male rat
  1724. Metabolic and ovarian consequences of perinatal sex steroid programming
  1725. Growth hormone-mediated breakdown of body fat: effects of GH on lipases in adipose tissue and skeletal muscle of old rats fed different diets
  1726. Prevention of atherosclerosis by bioactive palmitoleate through suppression of organelle stress and inflammasome activation
  1727. Steatosis and hepatitis C
  1728. Fighting Alzheimer’s disease and type 2 diabetes: pathological links and treatment strategies
  1729. insulin regulates retinol dehydrogenase expression and all-trans-retinoic acid biosynthesis through FoxO1
  1730. Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha.
  1731. Glucagon like peptide-1 (GLP-1) dynamics following bariatric surgery: a Signpost to a new frontier
  1732. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men
  1733. Treatment of genetically obese (ob/ob) mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin (AMP-DNM) increases fat oxidation …
  1734. Amino acid-sensing mTOR signaling is involved in modulation of lipolysis by chronic insulin treatment in adipocytes
  1735. Steatosis in chronic hepatitis C: why does it really matter?
  1736. Omega-3 fatty acids and skeletal muscle health
  1737. Adipokines and insulin resistance
  1738. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE* 3 Leiden and low …
  1739. Association of insulin-related serum factors with colorectal polyp number and type in adult males
  1740. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action
  1741. LOSS OF SKELETAL MUSCLE PKCθ PROTECTS AGAINST THE PATHOGENESIS OF insulin RESISTANCE
  1742. Treatment of genetically obese mice with the iminosugar AMP-DNM increases fat oxidation and decreases food intake
  1743. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals
  1744. Metabolic surgery in Zucker rats influenced miRNA, caveolin-1 expression and lipid metabolism
  1745. Sarcopenia in patients with chronic liver disease: can it be altered by diet and exercise?
  1746. Alterations in soleus muscle gene expression associated with a metabolic endpoint following exercise training by lean and obese Zucker rats
  1747. “Weighing” the effects of exercise and intrinsic aerobic capacity: are there beneficial effects independent of changes in weight?
  1748. Obesity and the skin: skin physiology and skin manifestations of obesity
  1749. Genome-wide pathway analysis for diabetic nephropathy in type 1 diabetes
  1750. A critical appraisal of the predictive adaptive response hypothesis
  1751. Polar lipid derangements in type 2 diabetes mellitus: potential pathological relevance of fatty acyl heterogeneity in sphingolipids
  1752. Glycolytic and mitochondrial metabolism in pancreatic islets from MSG-treated obese rats subjected to swimming training
  1753. FOXO transcription factors: their clinical significance and regulation
  1754. The gut microbiota: the gateway to improved metabolism
  1755. Amlexanox suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss
  1756. Fat cells: afferent and efferent messages define new approaches to treat obesity
  1757. Use of Microarrays to Investigate the Transcriptional Effects of Protein Tyrosine Phosphatase IB (PTP1B): Implications for Diabetes and Obesity
  1758. Biological mechanisms linking obesity and cancer risk: new perspectives
  1759. Minimizing Obesity With Hormone Replacement Therapy
  1760. Control of homeostatic and pathogenic balance in adipose tissue by ganglioside GM3
  1761. Supplemental Data Article Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle insulin Resistance
  1762. Nutrition in Metabolic Syndrome Topic 24
  1763. Glucosylceramide synthase in the fat body controls energy metabolism in Drosophila
  1764. Androgens and Coronary Artery Disease
  1765. Impaired plasma fatty acid oxidation in extremely obese women
  1766. Serum phospholipid docosahexaenoic acid is inversely associated with arterial stiffness in metabolically healthy men
  1767. Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes
  1768. A view on sphingolipids and disease
  1769. Emerging role of the GH/IGF-I on cardiometabolic control
  1770. The importance of steatosis in chronic hepatitis C infection and its management: a review
  1771. Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone
  1772. Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives
  1773. Detection of HISS-dependent insulin action: method considerations
  1774. Depressed DHEA and increased sickness response behaviors in lame dairy cows with inflammatory foot lesions
  1775. Continuous and intermittent exercise training and glucose metabolism in neonatal alloxan administered rats
  1776. 2012 New Investigator Award from the Neural Control and Autonomic Regulation (NCAR) Section of the American Physiological Society: The CNS glucagon …
  1777. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
  1778. The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatment.
  1779. The Pathophysiological Importance of Nicotinamide Phosphoribosyltransferase as a Key NAD Biosynthesis Enzyme in Metabolic Homeostasis
  1780. Gene expression signature in adipose tissue of acromegaly patients
  1781. TOPIC 06–Diabetes, dyslipidemia, metabolism
  1782. Department of Metabolic Diseases
  1783. Glycosphingolipid synthesis inhibitor AMP. DNM lowers plasma cholesterol levels by promoting fecal cholesterol excretion without inhibiting cholesterol absorption
  1784. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired …
  1785. Physiopathological function of hematoside (GM3 ganglioside)
  1786. Reduced histone H3K9 acetylation of clock genes and abnormal glucose metabolism in ob/ob mice
  1787. Development and validation of a high-resolution capillary electrophoresis method for multi-analysis of ragaglitazar and arginine in Active Pharmaceutical Ingredients …
  1788. Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus
  1789. Obesity, metabolic syndrome, and airway disease: a bioenergetic problem?
  1790. Mouse models to decipher the PI3K signaling network in human cancer
  1791. TRB3 suppresses adipocyte differentiation by negatively regulating PPARγ transcriptional activity
  1792. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis
  1793. Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver
  1794. WAT-free mice: diabetes without obesity
  1795. Regulation of Glut-4 Expression in Skeletal Muscle cells: The Roles of Nuclear Respiratory Factor-1 and calcium/calmodulin dependent protein Kinase
  1796. Accumulation of long-chain glycosphingolipids during aging is prevented by caloric restriction
  1797. Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans
  1798. Metabolic Actions of Growth Hormone
  1799. Effect of 1-deoxynojirimycin on cholesterol efflux through ABCA1-LXRα pathway in 3T3-L1 adipocytes
  1800. Mice heterozygous for the xanthine oxidoreductase gene facilitate lipid accumulation in adipocytes
  1801. New mechanisms contributing to hepatic steatosis: glucose, insulin, and lipid signaling
  1802. Prospects for pharmacologic inhibition of hepatic glucose production
  1803. Light-to-moderate ethanol feeding augments AMPK-α phosphorylation and attenuates SREBP-1 expression in the liver of rats
  1804. The effect of FoxO1 on glycemic control and skeletal muscle glucose uptake and lipid metabolism
  1805. DHEA in hair and glucose control in African-American adults
  1806. A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer’s disease
  1807. Identification of regulatory elements in the human adipose most abundant gene transcript-1 (apM-1) promoter: role of SP1/SP3 and TNF-α as regulatory pathways
  1808. Effect of electroacupuncture on inflammation in the obese zucker fatty rat model of metabolic syndrome
  1809. Loss of PDGF-B activity increases hepatic vascular
  1810. Exercise and postprandial glycemic control in type 2 diabetes
  1811. Association of serum dehydroepiandrosterone sulfate and cognition in older adults: sex steroid, inflammatory, and metabolic mechanisms.
  1812. insulin resistance states and insulin allergy
  1813. What’s New in Shock? January 2014
  1814. Inhibition of GSK3β by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer’s …
  1815. The role of leptin in obesity and diabetes mellitus in dog
  1816. The evolution of Fox genes and their role in development and disease
  1817. Clinical aspects of growth hormone deficiency in adults
  1818. The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?
  1819. Fox genes in glucose homeostasis
  1820. Drugs in sport: a scientist–athlete’s perspective: from ambition to neurochemistry
  1821. Degradation of STAT5 proteins in 3T3-L1 adipocytes is induced by TNF-α and cycloheximide in a manner independent of STAT5A activation
  1822. Glucose control and the inflammatory response
  1823. Correlation between Serum Dehydroepiandrosterone Sulfate and Coronary Artery Disease in Middle-Aged and Elderly Men
  1824. Metabolic lessons from genetically lean mice
  1825. Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor γ in adipocytes
  1826. Bibliography Current World Literature Vol 21 No 2 April 2010
  1827. VASCO DA GAMA UNIVERSITARY SCHOOL
  1828. Impact of light ethanol intake and of taurine, separately and together, on pathways of glucose metabolism in the kidney of diabetic rats
  1829. Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients
  1830. Lipidomics applications for disease biomarker discovery in mammal models
  1831. Newer therapies for diabetes management
  1832. Rapid and reversible induction of the longevity, anticancer and genomic effects of caloric restriction
  1833. Lipidomics as a principal tool for advancing biomedical research
  1834. Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue
  1835. mTORC1 and mTORC2 in energy homeostasis
  1836. Diet and longevity phenotype
  1837. Regulation of body weight
  1838. insulin Stimulated Lactate Production
  1839. Effect of cerebrocrast on body and organ weights, food and water intake, and urine output of normal rats
  1840. Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats
  1841. Glycosphingolipids and atherosclerosis
  1842. Gene prioritization based on biological plausibility over genome wide association studies renders new loci associated with type 2 diabetes
  1843. Differential Regulation of IGF-1 and insulin Signaling by GRKs
  1844. Berberine suppresses proinflammatory responses through AMPK activation in macrophages
  1845. Role of novel Russian adaptogenic compounds in restoration of adrenal function
  1846. Endocrine function after bariatric surgery
  1847. Complex Roles of Macrophages in Lipid Metabolism and Metabolic Disease: A Dissertation
  1848. Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy
  1849. Endoplasmic reticulum stress in nonalcoholic fatty liver disease
  1850. FOR APPROVAL
  1851. Mechanisms governing the health and performance benefits of exercise
  1852. 25 Adipose Tissue as a Target for Dehydroepiandrosterone and Its Sulfate
  1853. Claims for the anabolic effects of growth hormone: a case of the emperor’s new clothes?
  1854. Role of n-3 polyunsaturated fatty acids in ameliorating the obesity-induced metabolic syndrome in animal models and humans
  1855. Regulatory role of natural killer T cells in diabetes
  1856. Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis
  1857. Pharmacological Treatments for Obesity-Related Hypertension
  1858. Absence of Melatonin Induces Night-Time Hepatic insulin Resistance and
  1859. PRE AND POSTDOCTORAL FELLOWSHIPS
  1860. Metabolic and endocrine adaptations to heat stress in lactating dairy cows
  1861. Molecular Aspects of Obesity and insulin Resistance in Metabolic Syndrome and Neurological Disorders
  1862. Serum dehydroepiandrosterone sulfate and risk for type 2 diabetes in older men and women: the Pro. VA Study
  1863. Application of the speed-duration relationship to normalize the intensity of high-intensity interval training
  1864. Dehydroepiandrosterone in intracellular infectious diseases and related pathogens
  1865. Investigating the role of mir-190, mir-200, and mir-8 inhibition of the GCS protein in HeLa cells and Drosophila melanogaster
  1866. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity
  1867. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1, 6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison …
  1868. Inhibition of forkhead box O1 protects pancreatic β-cells against dexamethasone-induced dysfunction
  1869. Obesity-related derangements in metabolic regulation
  1870. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and …
  1871. Identification of novel GH-regulated pathway of lipid metabolism in adipose tissue: a gene expression study in hypopituitary men
  1872. Effects of increased dietary cholesterol with carbohydrate restriction on hepatic lipid metabolism in Guinea pigs
  1873. Role of angiotensin II in hepatic inflammation through MAPK pathway: a review
  1874. T lymphopenia in genetically obese-diabetic Wistar fatty rats: effects of body weight reduction on T cells
  1875. Novel Strategies to Improve Metabolic Parameters and Precondition Diabetic Hearts Against Ischemia/reperfusion Injury
  1876. 280 RETREATMENT WITH PEG-IFN ALPHA-2A PLUS RIBAVIRIN FOR 48 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 2 AND 3 RELAPSERS TO A …
  1877. Can sedentary time attenuate the acute effect of exercise on insulin action?
  1878. Freedom from Disease: The Breakthrough Approach to Preventing Cancer, Heart Disease, Alzheimer’s, and Depression by Controlling insulin
  1879. Diabetes, oxidative stress and therapeutic strategies
  1880. T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammation
  1881. Gene expression in skeletal muscle after an acute intravenous GH bolus in human subjects: identification of a mechanism regulating ANGPTL4
  1882. Sequestosome 1/p62 and TRAF6 are necessary for Akt ubiquitination, translocation and activation
  1883. Neuronal expression of glucosylceramide synthase in central nervous system regulates body weight and energy homeostasis
  1884. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent …
  1885. Testosterone-dependent vascular arachidonic acid metabolism in the regulation of insulin resistance and blood pressure
  1886. Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease
  1887. Mechanisms Mediating Antidiabetic Effects of Serviceberry extracts, Curcumin, and Stilbenes
  1888. An in vitro study on the influence of the pituitary gland on insulin secretion in lean and genetically obese mice
  1889. Circadian integration of hepatic de novo lipogenesis and peripheral energy substrates utilization
  1890. An Investigation of Antioxidant and Antidiabetic Effect of Aqueous Leaf Extracts of Mucuna Pruriens
  1891. Hunger Free Forever: The New Science of Appetite Control
  1892. The effects of obesity and different modes of training on the skeletal muscle microvasculature
  1893. DHEA induces 11β-HSD2 by acting on CCAAT/enhancer-binding proteins
  1894. Studies on insulin secretion and glucose tolerance in experimental obesity and diabetes.
  1895. Sumona Ghosh Lester, Simona S. Ghanem, and Sonia M. Najjar
  1896. Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the …
  1897. Activation of cyclic‐AMP response element binding protein contributes to adiponectin‐stimulated interleukin‐10 expression in raw 264.7 macrophages
  1898. Targeting mTOR Signaling Pathways in Liver Disease
  1899. Invited review: intracellular signaling in contracting skeletal muscle
  1900. Testosterone: a natural tonic for the failing heart?
  1901. Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase
  1902. Regulation of cytochrome P450 2B10 (CYP2B10) expression in liver by peroxisome proliferator-activated receptor-β/δ modulation of SP1 promoter occupancy
  1903. Clinical Physiopathology and Experimental Medicine
  1904. THE ROLE OF ER STRESS IN LIPOGENESIS AND insulin RESISTANCE IN RESPONSE TO OVER NUTRITION
  1905. Seasonal Adiposity and Delayed Ovulation in a Vespertilionid Bat, Scotophilus heathi: Role of Tumor Necrosis Factor‐α
  1906. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition
  1907. Effect of adrenalectomy and corticosterone replacement on meal patterns of Zucker rats
  1908. Relationships Between the Features of Metabolic Syndrome and Fatty Acids in the Diet, Plasma, and Adipose Tissue of Healthy Older Adults
  1909. Fermented Soy Product Isoflavone Composition, and Role in Gene Responses in C57BL/6 Mice
  1910. LST8 level controls basal p70 S6 kinase and Akt phosphorylations, and mTORC1 and mTORC2 negatively regulate each other by competing for association with …
  1911. Conflict of interest: None declared.
  1912. Sistema de Informação de Ciência e Tecnologia (SICT) 2012-INSTITUIÇÕES
  1913. Naturally occurring variants of the dysglycemic peptide pancreastatin: differential potencies for multiple cellular functions and structure-function correlation
  1914. Endothelial relaxation mechanisms and oxidative stress are restored by atorvastatin therapy in ovariectomized rats
  1915. Formation and signaling actions of electrophilic lipids
  1916. The Sick Adipocyte Theory: The Forces of Clustering at Glance
  1917. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family
  1918. Effect of rapid weight loss with supplemented fasting on serum electrolytes, lipids, and blood pressure
  1919. Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics
  1920. Autoimmunity, dehydroepiandrosterone (DHEA), and stress
  1921. Articles Published in Brazilian Journals Relevant to Sports and Exercise Medicine; a Review
  1922. Comparison of Two Different Sprint Interval Training Work-to-Rest Ratios on Acute Metabolic and Inflammatory Responses
  1923. Beta-arrestin2 is involved in the increase of distal colonic contraction in diabetic rats
  1924. CNS and peripheral mechanisms by which voluntary running wheel exercise affects adiposity and glucose metabolism
  1925. Dehydroepiandrosterone inhibits CD40/CD40L expression on human umbilical vein endothelial cells induced by interferon gamma
  1926. Physical activity protects the human brain against metabolic stress induced by a postprandial and chronic inflammation
  1927. The Role of AMPKα in High-Glucose-Induced Dysfunction of Cultured Rat Mesangial Cells
  1928. β-Arrestin-mediated receptor trafficking and signal transduction
  1929. Immunoresolving lipid mediators and resolution of inflammation in aging
  1930. Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and …
  1931. Comparison of milk fatty acid responses during fish oil-and trans-10 cis-12 18: 2-induced milk fat depression in dairy ewes
  1932. JNK signalling in cancer: in need of new, smarter therapeutic targets
  1933. Adrenalectomy fails to stimulate brown adipose tissue metabolism in ob/ob mice fed glucose
  1934. Strategies for the management of patients with obesity
  1935. Effect of Adiponectin Overexpression on the Metabolic Phenotype of the Ceacaml-/-Mouse
  1936. Increased lipid absorption and transport in the small intestine of zucker obese rats
  1937. IRS-1 and vascular complications in diabetes mellitus
  1938. The Antiobesity Effect of Dehydroepiandrosterone (DHEA): Clinical Studies in the Canine Model
  1939. Worming to Complete the insulin/IGF-1 Signaling Cascade: A Dissertation
  1940. Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis
  1941. Epigenetic regulation of glucose transporter 4 by estrogen receptor β
  1942. AMPK in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.
  1943. Management of growth hormone deficiency in adults
  1944. Estrogen receptors in health and disease
  1945. The role of adipocytes in tissue regeneration and stem cell niches
  1946. Sex hormones and immunosenescence
  1947. The metabolic basis of pulmonary arterial hypertension
  1948. ER Stress is Linked to the Regulation of Hepatic Gluconeogenesis and Phosphatidylinositol 3-kinase/Akt Signaling Post Burn Injury
  1949. Therapeutic Options in the Treatment of Diabetes
  1950. Eicosanoids in metabolic syndrome
  1951. The adrenal steroid status in relation to inflammatory cytokines (interleukin‐6 and tumour necrosis factor) in polymyalgia rheumatica
  1952. Identification of microRNAs as a potential novel regulatory mechanism in HSD11B1 expression
  1953. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects
  1954. Revisiting cAMP signaling in the carotid body
  1955. Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease
  1956. Alcoholic steatosis in different strains of rat: A comparative study
  1957. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle
  1958. Effects of an acute bout of passive hyperthermia therapy on glycemic control and blood pressure response in healthy individuals and type 2 diabetics
  1959. Genome-wide interaction-based association analysis identified multiple new susceptibility loci for common diseases
  1960. Exercise-induced differential changes in gene expression among arterioles of skeletal muscles of obese rats
  1961. The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors
  1962. The development of high fat diet induced adiponectin resistance in rodent skeletal muscle
  1963. Role of hypoxia-inducible factor 2α in the regulation of adipose tissue inflammation in obesity
  1964. Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study
  1965. Association between androgenic hormone levels and left ventricular ejection fraction
  1966. Could hormones make a difference in the treatment of juvenile rheumatoid arthritis?
  1967. In Vivo Role of JAK2 in the Pathogenesis of Obesity and the Metabolic Syndrome
  1968. How insulin binds to the insulin receptor
  1969. The Regulation of PREX2 by Phosphorylation
  1970. Effects on Roux-en-Y gastric bypass in male Wistar rats on fat preference, eating and bone metabolism
  1971. 9 Mineral Deficiencies
  1972. CENTRAL AND PERIPHERAL PEPTIDE REGULATION OF HUNGER, SATIETY AND FOOD
  1973. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis
  1974. Obesity and Weight Control
  1975. Screening candidate longevity therapeutics using gene-expression arrays
  1976. Social Isolation Stress, Obesity, and Breast Cancer Risk in Mice
  1977. Cross-talk between adipose and gastric leptins for the control of food intake and energy metabolism
  1978. Macrophage Polarization And Nitric Oxide Mechanisms In Lymphatic Dysfunction In A Rat Model Of Metabolic Syndrome
  1979. In Vivo Radioprotection by 5-Androstenediol: Stimulation of the Innate Immune System
  1980. Molecular determinants of the cardiometabolic phenotype
  1981. Cardiovascular function in animal models of metabolic syndrome and type 2 diabetes: the role of inducible nitric oxide synthase (iNOS)
  1982. Role of the Adipocyte in Development of Type 2 Diabetes
  1983. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease
  1984. Regulation of Metabolic Processes by Micrornas and Class I Histone Deacetylases
  1985. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory …
  1986. Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice
  1987. Low serum levels of dehydroepiandrosterone and cortisol in human diffuse cutaneous leishmaniasis by Leishmania mexicana
  1988. Mitochondria in cardiac disease
  1989. Dehydroepiandrosterone
  1990. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases–substitutes of adrenal and sex hormones
  1991. Flavonoids: Prospective strategy for the management of diabetes and its associated complications
  1992. Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice
  1993. The Physiology Of Mammalian ER Quality Control: Unfolded Protein Response And ER-Associated Degradation
  1994. Positive long-term outcomes from presuckling calcium supplementation in lactating rats and the offspring
  1995. Tanshinone IIA pretreatment attenuates hepatic ischemia-reperfusion
  1996. Liver monoamine oxidase in lean and obese (ob/ob) mice.
  1997. The VEGF receptor family
  1998. Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann–Pick C mice
  1999. Encapsulation of Fish Oil Using Texturized Whey Protein
  2000. Long-term effects of growth hormone replacement in hypopituitary adults on body composition, bone mass and cardiovascular risk factors
  2001. Cœur et androgenes
  2002. Regulation of Metabolism by Hepatic OXPHOS: A Dissertation
  2003. Schistosoma japonicum-associated morbidity and its mechanisms among children and young adults in the Philippines
  2004. GPA protects the nigrostriatal dopamine system by enhancing mitochondrial function
  2005. The Effects of Lipid Availability on Skeletal Muscle Metabolism in Lean and Obese Rodents and Humans
  2006. Does supplemental 18: 0 alleviate fish oil-induced milk fat depression in dairy ewes?
  2007. Trans-resveratrol induces a potential anti-lipogenic effect in lipopolysaccharide-stimulated enterocytes
  2008. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages
  2009. Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases
  2010. Noninsulin-dependent animal models of diabetes mellitus
  2011. Interventions in Aging and Age-Related Diseases: The Present and the Future
  2012. Studies on the Transcriptional and Enzymatic Control of Steroid Metabolism: Regulation by Lysosomal Acid Lipase, 24-Dehydrocholesterol Reductase, and Amyloid …
  2013. A role for the transcriptional repressor ICER in the molecular pathogenesis of type 2 diabetes
  2014. The role of stem cells in adipose tissue remodeling.
  2015. The role of mammalian target of rapamycin complex 1 in hepatic physiology and disease
  2016. Regulation of hepatic ER stress by the E3 ubiquitin ligase gp78 in zebrafish
  2017. TOPIC 01–Atherosclerosis, hemostasis, inflammation, AGE–A
  2018. Regulation of the memory T cell development and islet beta-cell survival by DAPK-related apoptosis-inducing protein kinase 2 (Drak2)
  2019. Inflammatory bowel disease part I: ulcerative colitis–pathophysiology and conventional and alternative treatment options
  2020. Acipimox during Short-Term Exercise Exerts A Negative Feedback of Growth Hormone on Ghrelin Secretion in Patients with Bulimia Nervosa and in Healthy Women …
  2021. Analysis of immune cell infiltration in white adipose tissue sites before and after bariatric surgery
  2022. of environmental substances on bone. More recently, natural diseases such as periodontitis have been studied in nonhuman primates. Experimental model diseases …
  2023. Hepatitis C: a retrospective study, literature review, and naturopathic protocol
  2024. Neuro-Immune Elements of Inflammatory Disease
  2025. Site-directed mutagenesis of the steroid-15beta-hydroxylase (CYP106A2) from Bacillus megaterium ATCC 13368 to alter the regio-selectivity of progesterone …
  2026. Challenges in the Management of Acromegaly
  2027. The STRIVE-ONR Project: Stress Resistance in Virtual Environments
  2028. The Healing Power of Flax: How Nature’s Richest Source of Omega-3 Fatty Acids Can Help to Heal, Prevent and Reverse Arthritis
  2029. The role of gut microbiota on obesity development
  2030. Eicosanoids in Metabolic Syndrome
  2031. Glycosphingolipids in HIV/AIDS: The Potential Therapeutic Application
  2032. Ruminant Supplementation of Gluconeogenic Substrates Via Drinking Water
  2033. Mechanisms of Methylglyoxal-elicited Leukocyte Recruitment
  2034. Regulation of ABCG5 and ABCG8 sterol transporters in biliary cholesterol elimination, reverse cholesterol transport and dyslipidemia
  2035. Diseases of the musculoskeletal system
  2036. Antifolate modulators of AMP-activated protein kinase signaling as cancer therapeutics
  2037. Programming of circadian rhythms in metabolic tissues by fetal glucocorticoid excess and the interactive effects of postnatal dietary fat manipulation
  2038. Novel Intrinsic and Extrinsic Approaches to Selectively Regulate Glycosphingolipid Metabolism
  2039. Vascular endothelial growth factor D: biology and function in transgenic and knockdown mice
  2040. Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats
  2041. Activation of Wnt/β‐catenin signaling restores insulin sensitivity in insulin resistant neurons through transcriptional regulation of IRS‐1
  2042. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
  2043. Loss of TAZ Boosts PPARγ to Cope with insulin Resistance
  2044. STAT1 dissociates adipose tissue inflammation from insulin sensitivity in obesity
  2045. Palmitic acid reduces the autophagic flux and insulin sensitivity through the activation of the free fatty acid receptor 1 (FFAR1) in the hypothalamic neuronal …
  2046. 4-PBA reverses autophagic dysfunction and improves insulin sensitivity in adipose tissue of obese mice via Akt/mTOR signaling
  2047. The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes
  2048. Senna alata leaf extract restores insulin sensitivity in high-fat diet-induced obese mice
  2049. Iron overload inhibits late stage autophagic flux leading to insulin resistance
  2050. Glucocorticoid‐induced insulin resistance in men is associated with suppressed undercarboxylated osteocalcin
  2051. Estrogen replacement enhances insulin-induced AS160 activation and improves insulin sensitivity in ovariectomized rats
  2052. Adipocyte JAK2 mediates growth hormone–induced hepatic insulin resistance
  2053. In vitro treatment of 3 T3-L1 adipocytes with recombinant Calcium/calmodulin-dependent Protein Kinase IV (CaMKIV) limits ER stress and improves insulin …
  2054. Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development
  2055. Inflammation and insulin resistance: New targets encourage new thinking: Galectin‐3 and LTB4 are pro‐inflammatory molecules that can be targeted to restore …
  2056. Chemical inducers of obesity-associated metabolic stress activate inflammation and reduce insulin sensitivity in 3T3-L1 adipocytes
  2057. Abscisic acid enriched fig extract promotes insulin sensitivity by decreasing systemic inflammation and activating LANCL2 in skeletal muscle
  2058. Carotid body dysfunction in diet-induced insulin resistance is associated with alterations in its morphology
  2059. SorCS1 binds the insulin receptor to enhance insulin sensitivity
  2060. Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes
  2061. Melatonin potentiates the effects of metformin on glucose metabolism and food intake in high‐fat‐fed rats
  2062. Effects of growth hormone on hepatic insulin sensitivity and glucose effectiveness in healthy older adults
  2063. Increased dynamin‐related protein 1–dependent mitochondrial fission contributes to high‐fat‐diet‐induced cardiac dysfunction and insulin resistance by elevating …
  2064. The evaluation of dietary black soybean and purple sweet potato on insulin sensitivity in streptozotocin-induced diabetic rats
  2065. N1-Methylnicotinamide Improves Hepatic insulin sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation
  2066. Undercarboxylated Osteocalcin Improves insulin‐Stimulated Glucose Uptake in Muscles of Corticosterone‐Treated Mice
  2067. Acyl ghrelin induces insulin resistance independently of GH, cortisol, and free fatty acids
  2068. Endoplasmic Reticulum Stress Inhibition by TUDCA Restores insulin Resistance in Patients With Diabetes Mellitus
  2069. A severe but reversible reduction in insulin sensitivity is observed in patients with insulinoma
  2070. Efficacy of a six-week dispersed Wingate-cycle training protocol on peak aerobic power, leg strength, insulin sensitivity, blood lipids and quality of life in healthy adults
  2071. Potential application of testosterone replacement therapy as treatment for obesity and type 2 diabetes in men
  2072. Effect of dehydroepiandrosterone (DHEA) on diabetes mellitus and obesity
  2073. GLP-1 analogue liraglutide attenuates mutant huntingtin-induced neurotoxicity by restoration of neuronal insulin signaling
  2074. Testosterone increases the expression and phosphorylation of AMP kinase α in men with hypogonadism and type 2 diabetes
  2075. Pu’erh tea extract-mediated protection against hepatosteatosis and insulin resistance in mice with diet-induced obesity is associated with the induction of de novo …
  2076. insulin sensitivity is mediated by glucose in the hepatoportal region in the rat
  2077. Interferon beta overexpression attenuates adipose tissue inflammation and high-fat diet-induced obesity and maintains glucose homeostasis
  2078. Short-term fasting restores free-choice high-fat, high sugar diet-induced insulin resistance in rats
  2079. Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review
  2080. insulin signaling in the whole spectrum of GH deficiency
  2081. Independent Effect of High Aerobic Capacity To Protect Against Diet-Induced insulin Resistance in Male Rats
  2082. The response of insulin signaling proteins IRS1 and PTP-1B to endurance, HIIT and resistance training in rats with experimental diabetes
  2083. Infliximab ameliorates tumor necrosis factor‐alpha‐induced insulin resistance by attenuating PTP 1B activation in 3T3L1 adipocytes in vitro
  2084. Spinophilin-deficient mice are protected from diet-induced obesity and insulin resistance
  2085. SAT-653 Exploring the Role of Brown Adipokines on Hepatic insulin Resistance Using a Microfluidic Organ-On-Chip
  2086. Are marine n-3 fatty acids protective towards insulin resistance? From cell to human
  2087. Glucoraphanin ameliorates obesity and insulin resistance through adipose tissue browning and reduction of metabolic endotoxemia in mice
  2088. Roux-en-Y Gastric Bypass Restores Islet Function and Morphology Independent of Body Weight in ZDF Rats
  2089. Bariatric surgery normalizes circulating glucocorticoid levels and lowers glucocorticoid action tissue-selectively in mice
  2090. Reduced oxygen consumption by fat cells improves metabolic defects
  2091. Liraglutide ameliorates hyperhomocysteinemia-induced Alzheimer-like pathology and memory deficits in rats via multi-molecular targeting
  2092. GM3, Caveolin-1 and insulin Receptor in insulin Resistance
  2093. The role of metabolic rate and substrate utilization in the maintenance of body weight, body composition and insulin sensitivity
  2094. A novel metformin‐methylglyoxal imidazolinone metabolite (IMZ) sensitizes cells to insulin; a potential role in alleviating T2DM complications
  2095. THE EFFECTS OF DEHYDROEPIANDROSTERONE (DHEA) ON DIABETES MELLITUS, OBESITY, AND ATHEROSCLEROSIS
  2096. Attenuation of obesity and insulin resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat diet
  2097. Absence of carbohydrate response element binding protein in adipocytes causes systemic insulin resistance and impairs glucose transport
  2098. Implications of palmitoleic acid (palmitoleate) on glucose homeostasis, insulin resistance and diabetes
  2099. Dietary supplementation of vitamin D prevents the development of western diet-induced metabolic, hepatic and cardiovascular abnormalities in rats
  2100. Latent inflammation and defect in adipocyte renewal as a mechanism of obesity-associated insulin resistance
  2101. 2-Methoxyestradiol inhibits high fat diet-induced obesity in rats through modulation of adipose tissue macrophage infiltration and immunophenotype
  2102. Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
  2103. Do flavanols-rich natural products relieve obesity-related insulin resistance?
  2104. The chemokine CXCL16 can rescue the defects in insulin signaling and insulin sensitivity caused by palmitate in C2C12 myotubes
  2105. β-adrenergic receptor and insulin resistance in the heart
  2106. BDNF mimetic alleviates body weight gain in obese mice by enhancing mitochondrial biogenesis in skeletal muscle
  2107. Agmatine ameliorates type 2 diabetes induced-Alzheimer’s disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling
  2108. Exercise and metabolic health: beyond skeletal muscle
  2109. Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration
  2110. Intermittent walking, but not standing, improves postprandial insulin and glucose relative to sustained sitting: a randomised cross-over study in inactive middle-aged …
  2111. Amelioration of high-insulin-induced skeletal muscle cell insulin resistance by resveratrol is linked to activation of AMPK and restoration of GLUT4 translocation
  2112. Targeting metabolic consequences of insulin resistance in polycystic ovary syndrome by D-chiro-inositol and emerging nutraceuticals: a focused review
  2113. insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2× 2 …
  2114. Mitochondria-associated membranes (MAMs): a novel therapeutic target for treating metabolic syndrome
  2115. Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome
  2116. DHA-enriched fish oil reduces insulin resistance in overweight and obese adults
  2117. The effect of metaformin treatment on insulin resistance in women with polycystic ovary syndrome
  2118. insulin resistance in patients with acromegaly
  2119. The effect of handcycle ergometer exercise on glucose tolerance in ambulatory and non-ambulatory adolescents
  2120. GPRC6A: Jack of all metabolism (or master of none)
  2121. Combined Hyperglycemia- and Hyperinsulinemia-Induced insulin Resistance in Adipocytes Is Associated With Dual Signaling Defects Mediated by PKC-ζ
  2122. SUN-094 Long-Term Safety and Efficacy of Leuprorelin in Treating Central Precocious Puberty: A Large, Open-Label, Multicenter, Phase IV Study in China
  2123. N-Acetyl-l-Cysteine treatment efficiently prevented pre-diabetes and inflamed-dysmetabolic liver development in hypothalamic obese rats
  2124. Inflammation is not a contributing factor in the development of insulin resistance in diet induced obesity in rats
  2125. Carnitine palmitoyltransferase 2 knockout potentiates palmitate-induced insulin resistance in C2C12 myotubes
  2126. Aging induces an Nlrp3 inflammasome-dependent expansion of adipose B cells that impairs metabolic homeostasis
  2127. Androgen profile in young females with insulin resistance; the importance of 17-Hydroxyprogesterone: Androgens in young insulin resistant females
  2128. Effects of central FGF21 infusion on the hypothalamus–pituitary–thyroid axis and energy metabolism in rats
  2129. Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing
  2130. Hepatic insulin clearance: mechanism and physiology
  2131. Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis
  2132. Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis
  2133. DPP-4 inhibition with anagliptin reduces lipotoxicity-induced insulin resistance and steatohepatitis in male mice
  2134. Effect of growth hormone on insulin signaling
  2135. Accumulation of intramuscular toxic lipids, a link between fat mass accumulation and sarcopenia
  2136. Lycopene Alleviates Obesity‐Induced Inflammation and insulin Resistance by Regulating M1/M2 Status of Macrophages
  2137. Metabolic relationship between diabetes and Alzheimer’s disease affected by Cyclo (His-Pro) plus zinc treatment
  2138. Growth Hormone and Obesity
  2139. Modulation of insulin resistance and the adipocyte-skeletal muscle cell cross-talk by LCn-3PUFA
  2140. Fatty Acid Biology and Nutrition to Optimize Health and Production
  2141. The effects of growth hormone on adipose tissue: Old observations, new mechanisms
  2142. The UPRER: sensor and coordinator of organismal homeostasis
  2143. Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice
  2144. Impact of lipid metabolism on skeletal muscle mitochondrial function in type 2 diabetes mellitus patients
  2145. EFFECT OF BREWED ROBUSTA COFFEE LEAVES ON insulin LEVELS AND HOMA-IR INDEX IN METABOLIC SYNDROME RATS
  2146. Inflammation markers in type 2 diabetes and the metabolic syndrome in the pediatric population
  2147. FGF21 gene therapy as treatment for obesity and insulin resistance
  2148. The role of the novel lipokine palmitoleic acid in health and disease
  2149. The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS …
  2150. Reduced mitochondrial translation prevents diet-induced metabolic dysfunction but not inflammation
  2151. Hypothalamic proopiomelanocortin is necessary for normal glucose homeostasis in female mice
  2152. The role of dehydroepiandrosterone (DHEA) in skeletal muscle
  2153. The therapeutic potential of FGF21 in metabolic diseases: From bench to clinic
  2154. Unacylated ghrelin stimulates fatty acid oxidation to protect skeletal muscle against palmitate-induced impairment of insulin action in lean but not high-fat fed …
  2155. Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
  2156. In utero low-protein-diet-programmed type 2 diabetes in adult offspring is mediated by sex hormones in rats
  2157. Identification of two microRNA nodes as potential cooperative modulators of liver metabolism
  2158. Growth hormone acts along the PPARγ-FSP27 axis to stimulate lipolysis in human adipocytes
  2159. Plasma irisin modestly increases during moderate and high-intensity afternoon exercise in obese females
  2160. Liraglutide alters hepatic metabolism in high-fat fed obese mice: A bioinformatic prediction and functional analysis
  2161. A comparative study on the effect of argan oil versus fish oil on risk factors for cardio-vascular disease in high-fat-fed rats
  2162. Gestational diabetes mellitus prediction? A unique fatty acid profile study
  2163. Pumonary and systemic endothelial function in diabetic animal models: effect of carotid sinus nerve denervation
  2164. adiponectin gene therapy for alzheimer disease in a mouse model: abridged secondary
  2165. Inflammatory markers in children and adolescents with type 2 diabetes mellitus
  2166. SUN-193 A Case of Cushing’s Syndrome Caused by Epidural Corticoidsteroid Injection
  2167. “insulin-like” effects of palmitate compromise insulin signalling in hypothalamic neurons
  2168. Ileal transposition surgery decreases fat mass and improves glucose metabolism in diabetic GK rats: possible involvement of FGF21
  2169. The shutting down of the insulin pathway: a developmental window for Wolbachia load and feminization
  2170. Supplementation with Seabuckthorn Oil Augmented in 16:1n–7t Increases Serum Trans-Palmitoleic Acid in Metabolically Healthy Adults: A Randomized Crossover …
  2171. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations
  2172. A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice
  2173. Growth hormone controls lipolysis by regulation of FSP27 expression
  2174. Circulating micro RNA in insulin resistant horses
  2175. Transgenerational supplementation with eicosapentaenoic acid reduced the metabolic consequences on the whole body and skeletal muscle in mice receiving an …
  2176. Pathogenesis of Pancreatic Cancer-Related Diabetes Mellitus: Quo Vadis?
  2177. Aging induces Nlrp3 inflammasome dependent adipose B cell expansion to impair metabolic homeostasis
  2178. The biology of gangliosides
  2179. Adipocytes harbor a glucosylceramide biosynthesis pathway involved in iNKT cell activation
  2180. Interrupting prolonged sitting in type 2 diabetes: nocturnal persistence of improved glycaemic control
  2181. Regulation of adipose tissue and skeletal muscle substrate metabolism by the stomach-derived hormone, ghrelin
  2182. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effects vs. clinical outcomes
  2183. Dipeptidyl peptidase-4 inhibitor, vildagliptin, improves trabecular bone mineral density and microstructure in obese, insulin-resistant, pre-diabetic rats
  2184. Ganglioside GM3 mediates glucose-induced suppression of IGF-1 receptor–Rac1 activation to inhibit keratinocyte motility
  2185. Interfering PLD1-PED/PEA15 interaction using self-inhibitory peptides: An in silico study to discover novel therapeutic candidates against type 2 diabetes
  2186. Polycystic ovary syndrome: insights into the therapeutic approach with inositols
  2187. Effects of exercise intensity on RBP4 levels in female athletes
  2188. Omega-3 polyunsaturated fatty acids prevent obesity by improving tricarboxylic acid cycle homeostasis
  2189. THERAPY OF ENDOCRINE DISEASE: Growth hormone replacement therapy in adults: 30 years of personal clinical experience
  2190. The fatty acid-rich fraction of Eruca sativa (rocket salad) leaf extract exerts antidiabetic effects in cultured skeletal muscle, adipocytes and liver cells
  2191. Non-alcoholic fatty liver disease and nutritional implications: special focus on copper
  2192. Glucose-sensing transcription factor mondoa/ChREBP as targets for type 2 diabetes: Opportunities and challenges
  2193. Scutellarin, a modulator of mTOR, attenuates hepatic insulin resistance by regulating hepatocyte lipid metabolism via SREBP‐1c suppression
  2194. Partial replacement of corn oil with chia oil into a high fat diet produces either beneficial and deleterious effects on metabolic and vascular alterations in rabbits
  2195. Ablation of the carotid bodies in disease: meeting its adverse effects
  2196. β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice
  2197. Interleukin-4 improves metabolic abnormalities in leptin-deficient and high-fat diet mice
  2198. The effect of metformin treatment on the basal and gonadotropin‐stimulated steroidogenesis in male rats with type 2 diabetes mellitus
  2199. Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2
  2200. Gene Expression and Clinical Manifestations in Iraqi Patients with Acromegaly
  2201. Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice
  2202. Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
  2203. Central Regulation of Metabolism by Growth Hormone
  2204. insulin does not rescue cortical and trabecular bone loss in type 2 diabetic Goto-Kakizaki rats
  2205. Gene therapy of type 2 diabetes mellitus: state of art
  2206. Hypolipidemic and Antioxidant Effects of Citrullus colocynthis Seeds Oil in High-Fat Diets Induced Obese Rats
  2207. Docosahexaenoic and eicosapentaenoic fatty acids differentially regulate glucose and fatty acid metabolism in L6 rat skeletal muscle cells
  2208. Intergenerational impact of maternal overnutrition and obesity throughout pregnancy in sheep on metabolic syndrome in grandsons and granddaughters
  2209. The regulation of lipokines by environmental factors
  2210. Thyroid Hormone and Metabolites: Central Versus Peripheral Effects
  2211. Effects of periconception cadmium and mercury co-administration to mice on indices of chronic diseases in male offspring at maturity
  2212. USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes
  2213. Testing the metabolic sink postulate: Subcutaneous adipose tissue the protective depot
  2214. The iminosugar AMP-DNM improves satiety and activates brown adipose tissue through GLP1
  2215. Hibernation induces widespread transcriptional remodeling in metabolic tissues of the grizzly bear
  2216. Graphical abstract Chapter 4: PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
  2217. Endogenous Adipocyte-derived Glucosylce-ramides Drive iNKT Cell Function
  2218. Regulation of Postabsorptive and Postprandial Glucose Metabolism by insulin-Dependent and insulin-Independent Mechanisms: An Integrative Approach
  2219. Different roles of insulin receptor a and b in maintaining blood glucose homeostasis in zebrafish
  2220. The impact of obesity on cardiovascular disease risk factor
  2221. Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS?
  2222. Monounsaturated Fatty Acids in Obesity-Related Inflammation
  2223. Reduced delta-6 desaturase activity partially protects against high-fat diet-induced impairment in whole-body glucose tolerance
  2224. Effects of urocortin 2 versus urocortin 3 gene transfer on left ventricular function and glucose disposal
  2225. Body Composition Changes with Long-term Pegvisomant Therapy of Acromegaly
  2226. Role of Forkhead Box O (FOXO) transcription factor in aging and diseases
  2227. Prenatal steroids and metabolic dysfunction: lessons from sheep
  2228. Temporal patterns of lipolytic regulators in adipose tissue after acute growth hormone exposure in human subjects: a randomized controlled crossover trial
  2229. Therapeutic application of GPR119 ligands in metabolic disorders
  2230. Berberine in the treatment of metabolism-related chronic diseases: a drug cloud (dCloud) effect to target multifactorial disorders
  2231. Adipose Tissue Composition in Obesity and After Bariatric Surgery
  2232. Lower Serum Fibroblast Growth Factor 21 Levels are Associated with Normal Lumbar Spine Bone Mineral Density in Hemodialysis Patients
  2233. Identifying New Treatment Options and Risk Factors for Type 2 Diabetes: The Potential Role of Thymoquinone and Persistent Organic Pollutants
  2234. Solute excretion, metabolism, and cardio‐renoprotection via two distinct mechanisms revolutionize clinical outcomes
  2235. Normal physiology of growth hormone in adults
  2236. Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review
  2237. Modulation of the carotid body activity to treat obesity
  2238. The shutting down of the insulin pathway: a developmental window for Wolbachia load and feminization
  2239. “insulin-Like” Effects of Palmitate Might Contribute to the Development of insulin Resistance in Hypothalamic Neurons
  2240. PANDORA
  2241. Growth hormone upregulates ANGPTL4 mRNA and suppresses lipoprotein lipase via fatty acids: randomized experiments in human individuals
  2242. Nutraceuticals and diet in human health and disease. The special issue at a glance
  2243. Effects of abomasal infusions of fatty acids and one-carbon donors on hepatic ceramide and phosphatidylcholine in lactating Holstein dairy cows
  2244. The Iminosugar AMP-DNM Improves Satiety and Activates Brown Adipose Tissue Through GLP1
  2245. Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice
  2246. Pharmacological effects of palmitoylethanolamide on hypertension, insulin-resistance and obesity in murine models
  2247. The future of liver transplantation for viral hepatitis
  2248. Central Regulation of Metabolism by Growth Hormone. Cells 2021, 10, 129
  2249. Glycosphingolipids and infection. Potential new therapeutic avenues
  2250. DUSP5 functions as a feedback regulator of TNFα-induced ERK1/2 dephosphorylation and inflammatory gene expression in adipocytes
  2251. Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome
  2252. Metabolic implications of organelle–mitochondria communication
  2253. Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis?
  2254. Age‐related bone loss is associated with FGF21 but not IGFBP1 in healthy adults
  2255. Sphingolipids in adipose tissue: What’s tipping the scale?
  2256. Partial remission (honeymoon phase) in type 1 diabetes mellitus
  2257. Endothelial dysfunction in obesity
  2258. Sirtuins and their biological relevance in aging and age-related diseases
  2259. Evidence that a mitochondrial death spiral underlies antagonistic pleiotropy
  2260. Therapeutic effects of fibroblast growth factor‑21 against atherosclerosis via the NF‑κB pathway
  2261. Regulation of adipose tissue inflammation and systemic metabolism in murine obesity by polymer implants loaded with lentiviral vectors encoding human interleukin …
  2262. Neck circumference as an independent predictor for NAFLD among postmenopausal women with normal body mass index
  2263. Caloric restriction in heart failure: A systematic review
  2264. Omega-3 Polyunsaturated Fatty Acids Mitigate Palmitate-Induced Impairments in Skeletal Muscle Cell Viability and Differentiation
  2265. Interactions among mTORC, AMPK, and SIRT: A Computational Model for Cell Energy Balance and Metabolism
  2266. Obesity and aging in the Drosophila model
  2267. The use of herbal remedies in the treatment of hepatobiliary diseases: trends and prospects
  2268. Adipose tissue function and expandability as determinants of lipotoxicity and the metabolic syndrome
  2269. Whole egg consumption increases gene expression within the glutathione pathway in the liver of Zucker Diabetic Fatty rats
  2270. Flavonoids, dairy foods, and cardiovascular and metabolic health: a review of emerging biologic pathways
  2271. Potential molecular mechanism of probiotics in alcoholic liver disease
  2272. Evaluation of metabolic changes in liver and serum of streptozotocin-induced diabetic rats after Mango diet supplementation
  2273. Extra-Virgin Olive Oil and Type 2 Diabetes Mellitus
  2274. Drug treatment strategies for secondary diabetes in patients with acromegaly
  2275. Effects of grape pomace and a polyphenolic plant product during the transition period of high-yielding dairy cows: kumulative Dissertation
  2276. Fructose Intake: Metabolism and Role in Diseases
  2277. Phospholipase D As a Potential Modulator of Metabolic Syndrome: Impact of Functional Foods
  2278. Betaine promotes lipid accumulation in adipogenic-differentiated skeletal muscle cells through ERK/PPARγ signalling pathway
  2279. Use of Oral Citrulline Administration as a Mitigation Strategy for Fescue Toxicosis in Sheep
  2280. Fit with good fat? The role of n-3 polyunsaturated fatty acids on exercise performance
  2281. The Roles of CD2AP and SHIP2 in insulin Resistance and Podocyte Apoptosis
  2282. Alcohol, adipose tissue and lipid dysregulation
  2283. Neuroprotective effects of docosahexaenoic acid against sub-acute manganese intoxication induced dopaminergic and motor disorders in mice
  2284. EPA and DHA inhibit myogenesis and downregulate the expression of muscle-related genes in C2C12 Myoblasts
  2285. Effects of a dietary supplement enriched in palmitoleic acid on fatty acid composition of follicular fluid, granulosa cell metabolism, and oocyte developmental capacity …
  2286. The potential mechanisms of exercise-induced cognitive protection: A literature review.
  2287. Derangement of calcium metabolism in diabetes mellitus: negative outcome from the synergy between impaired bone turnover and intestinal calcium absorption
  2288. Endoplasmic reticulum stress in metabolic disorders
  2289. Fatty acids and NLRP3 inflammasome–mediated inflammation in metabolic tissues
  2290. Nutrigenomics of marbling and fatty acid profile in ruminant meat
  2291. Induction of stearoyl-CoA 9-desaturase 1 protects human mesenchymal stromal cells against palmitic acid-induced lipotoxicity and inflammation
  2292. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B
  2293. Health-Promoting Activities of Nigella sativa Fixed Oil
  2294. Control of polyunsaturated fatty acids desaturation by Sting regulates inflammatory responses
  2295. Bariatric Surgery for Obesity and Metabolic Syndrome
  2296. Ethnobotanical description and biological activities of Senna alata
  2297. Prognos c value of dehydroepiandrosterone in type 2 diabetes: The Ro erdam Study
  2298. Dietary EPA increases rat mortality in diabetes mellitus, a phenomenon which is compensated by green tea extract
  2299. Transgenerational effects of periconception heavy metal administration on adipose weight and glucose homeostasis in mice at maturity
  2300. Emptying the DUSP Bin: A Role for DUSP5 in Adipose Tissue Inflammation
  2301. Emptying Out the DUSP Bin: A Role for DUSP5 in Adipose Tissue Inflammation
  2302. Nutritional quality of different grades of adult male chinese mitten crab, Eriocheir sinensis
  2303. Cellular responses in rainbow trout (Oncorhynchus mykiss) reared in tritiated water and/or fed organically bound tritium
  2304. High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients
  2305. Correction of cilia structure and function alleviates multi-organ pathology in Bardet–Biedl syndrome mice
  2306. Protracted rosiglitazone treatment exacerbates inflammation in white adipose tissues of adipocyte-specific Nfe2l1 knockout mice
  2307. Effects of dietary inclusion of high concentrations of crude glycerin on meat quality and fatty acid profile of feedlot fed Nellore bulls
  2308. Disentangling host-microbiota regulation of lipid secretion by enterocytes: insights from commensals lactobacillus paracasei and Escherichia coli
  2309. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer’s disease by restoring …
  2310. Therapeutic approaches to diabetic cardiomyopathy: Targeting the antioxidant pathway
  2311. Myriocin and d-PDMP ameliorate atherosclerosis in ApoE−/− mice via reducing lipid uptake and vascular inflammation
  2312. Sphingolipid signaling in renal fibrosis
  2313. Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses
  2314. Math and the Fountain of Youth
  2315. Effects of apoptosis on liver aging
  2316. Comparison of the Nutritional Quality of Three Edible Tissues from Precocious and Normal Adult Female Chinese Mitten Crabs (Eriocheir sinensis)
  2317. Tuberculosis, the disrupted immune-endocrine response and the potential thymic repercussion as a contributing factor to disease physiopathology
  2318. Functional analysis of Cullin 3 E3 ligases in tumorigenesis
  2319. Adipose Tissue Function and
  2320. Chitosan and cottonseed processing method association on carcass traits and meat quality of feedlot lambs
  2321. High mobility group box-1 (HMGb1): current wisdom and advancement as a potential drug target: miniperspective
  2322. Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for …
  2323. Bovine Stearoyl-CoA Desaturase 1 Promotes Adipogenesis by Activating the PPARγ Receptor
  2324. Neuroendocrine and inflammatory responses to DHEA administration in young healthy women
  2325. Bone and Muscle Crosstalk in Aging
  2326. Regulation of Skeletal Muscle Glucose and Fat Metabolism by DHA and EPA
  2327. Redox signaling in the pathogenesis of human disease and the regulatory role of autophagy
  2328. MicroRNA‑100‑5p inhibits osteoclastogenesis and bone resorption by regulating fibroblast growth factor 21
  2329. Fetal programming of adult disease: Causes and consequences of metabolic dysregulation in an ovine model of PCOS
  2330. Roles and functions of the unconventional prefoldin URI
  2331. Epigenetic transgenerational inheritance
  2332. Molecular signaling in bone cells: regulation of cell differentiation and survival
  2333. Chronic Infections and the Hypothalamus-Pituitary-Adrenal Axis in the Context of Immune-Mediated Inflammation
  2334. Generation of Functional Brown Adipocytes from Human Pluripotent Stem Cells via Progression through a Paraxial Mesoderm State
  2335. Protective effects of omega-3 fatty acids in cancer-related complications
  2336. Adiponectin-based Therapeutics in Cancer Treatment
  2337. Chronic consumption of a high-fat diet: investigation of negative consequences
  2338. Ergot alkaloid exposure during gestation alters. I. Maternal characteristics and placental development of pregnant ewes
  2339. Metabolic responses of BV‐2 cells to puerarin on its polarization using ultra‐performance liquid chromatography–mass spectrometry
  2340. METFORMIN: A TOOL TO BETTER UNDERSTAND T CELL MEDIATED PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS
  2341. NADPH Oxidase Inhibition in Fibrotic Pathologies
  2342. Systems Biochemistry Investigation into Lipid Metabolism and Lipid-Metabolizing Enzymes
  2343. PTPN9-mediated dephosphorylation of VTI1B promotes ATG16L1 precursor fusion and autophagosome formation
  2344. Nutritional regulation of the hepatokine FGF21 in the liver: interdependence of the transcription factors ChREBP and PPARα
  2345. Glycosphingolipids and the central regulation of metabolism: Sugar analogues as research tools
  2346. The Role of Palmitoleate in Hypertension and Cardiac Hypertrophy
  2347. Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy
  2348. Cortisol-dehydroepiandrosterone ratios are inversely associated with hippocampal and prefrontal brain volume in schizophrenia
  2349. BONTHRON EDITED–ORIGINAL ARTICLE
  2350. Role of MicroRNAs and Unfolded Protein Response in Breast Cancer
  2351. Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney Rampanelli, Elena; Ochodnicky, Peter; Vissers …
  2352. Experiences of young adults living with type 1 diabetes mellitus regarding self-management and lifestyle adaptation in the Nelson Mandela Bay Health District
  2353. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination
  2354. Metformin: A Tool to Better Understand T Cell Mediated Protection against Mycobacterium tuberculosis
  2355. Antioxidant and cardioprotective effects of EPA on early low-severity sepsis through UCP3 and SIRT3 upholding of the mitochondrial redox potential
  2356. Dietary Restriction, Physical Activity, and Metabolism; Potential Role of Intermittent Fasting for Reducing Obesity
  2357. Role of Invariant Natural Killer T Cell Subsets in Adipose Tissue Homeostasis
  2358. Supplementation of glycerol or fructose via drinking water to grazing lambs on tissue glycogen level and lipogenesis
  2359. The efficacy of functional foods for the mitigation of obesity-related pathologies
  2360. The Regulation of FoxO1 by Glucose-6-Phosphate Dehydrogenase and O-linked N-Acetyl-Glucosamine Modification
  2361. Reprogramming of Th1 cells into regulatory T cells through rewiring of the metabolic status
  2362. Development of Linear and Branched Pre-pegylated Amino Acids for Site-specific Peptide Incorporation
  2363. Invited review: Role of rumen biohydrogenation intermediates and rumen microbes in diet-induced milk fat depression: An update
  2364. The First Time Design of Cancer Nutrition as Specific to Treatment with Its Mega Analysis, Potential, Benefits, and Drawbacks

Related Posts

Shopping Cart
Scroll to Top